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In cell metabolism, substrate channeling is a phenomenon where the product of
one reaction is transported to a second enzyme active site without equilibrating into bulk
solvent. Chapter 1 reviews the rationale and evidence for substrate channeling with the
specific example of proline metabolism. Oxidation of proline to glutamate is catalyzed in
consecutive reactions by proline dehydrogenase (PRODH) and pyrroline-5-carboxylate
dehydrogenase (P5CDH). The intermediate Δ1-pyrroline-5-carboxylate reportedly tends
to be labile and inhibitory towards several metabolic pathways.
One of the main objectives of this dissertation was to investigate substrate
channeling between independent proline oxidative enzymes from Thermus thermophilusTtPRODH and TtP5CDH. Chapter 2 establishes that TtPRODH and TtP5CDH are
capable of interacting with a dissociation constant (KD) of 3.03 µM as demonstrated using
Surface Plasmon Resonance (SPR). As observed in the present study, this interaction is
possible only with a specific orientation of TtPRODH relative to TtP5CDH. A docking
model of the two enzymes predicts an orientation of the active sites which is supportive
of substrate channeling. Corroborating observations are made with kinetic studies. We
observe that interference of TtPRODH-TtP5CDH complex by catalytically inactive
mutants TtPRODH R288M/R289M and TtP5CDH C322A lead to significant decrease in

glutamate formation. The results pave the way for testing substrate channeling in
eukaryotic enzymes. In chapter 3, two novel eukaryotic enzymes from Saccharomyces
cerevisiae, Put1p (PRODH) and Put2p (P5CDH), have been characterized. Particular
attention was focused on the oxidative half-reaction of Put1p for gaining insight into
possible redox functions of human PRODH.
Previous studies show that bifunctional enzyme from Gram-negative
Bradyrhizobium japonicum (BjPutA) containing PRODH and P5CDH domains, exhibits
substrate channeling via an elegant internal tunnel. BjPutA and its channeling variants
were used to test the role of substrate channel in hydrolysis of P5C, an essential step in
proline oxidation. These aspects of substrate channeling are discussed in chapter 4.
Overall, this study provides an improved understanding of: (1) Substrate
channeling in proline oxidation; and (2) a model for investigating substrate channeling
between other individual enzymes that catalyze consecutive reactions.
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CHAPTER 1
Introduction:
Substrate channeling in proline
metabolism
Note: This chapter has been published as a review article: “Substrate channeling in
proline metabolism.” Arentson BW, Sanyal N, Becker DF. Front Biosci. 2012 Jan
1;17:375-88. Permission for usage in thesis obtained from Frontiers of Bioscience.
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INTRODUCTION
It is well known that proline metabolism has important roles in carbon and
nitrogen flux and protein synthesis. Proline metabolism has also emerged as a relevant
pathway in other processes such as cell signaling, cellular redox balance, and apoptosis
[1-3]. Proline homeostasis is important in human disease, where inborn errors in proline
metabolism are thought to lead to neurological dysfunctions such as schizophrenia and
febrile seizures, as well as errors in systemic ammonia detoxification and developmental
disorders such as skin hyperelasticity [4-7]. Recently it was shown that mutations that
disrupt proline biosynthesis are linked with progeroid features and osteopenia that are
part of the autosomal recessive cutis laxa syndrome [8]. In bacteria and plants, proline
metabolism is responsive to various environmental stresses such as drought, osmotic
pressure, or ultraviolent irradiation leading to proline accumulation as a survival
mechanism [9-11]. Overall proline has become a very important metabolite that is
thought to be involved in many cellular processes.
Fundamental to understanding the roles of proline metabolism in various
processes is knowledge of the relevant enzymes and mechanisms used to maintain proper
proline homeostasis. In this review, the unique aspect of substrate channeling in proline
metabolism will be explored.

Insights into the channeling mechanisms of enzymes

responsible for the catabolism and biosynthesis of proline are helping to reveal the many
roles of proline within the cell. Here we review the structural and kinetic data that support
substrate channeling of P5C/GSA and gamma–glutamyl phosphate in the proline
catabolic and biosynthetic pathways, respectively. The data indicate that both
intermediates are channeled which increases the efficiency of proline metabolic flux.
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PROLINE METABOLIC ENZYMES
Proline catabolism
The catabolic and anabolic reactions of proline metabolism are shown in Figure 1.
The catabolic pathway generates glutamate from the four electron oxidation of proline,
which occurs in two catalytic steps [12].

In the first step, proline dehydrogenase

(PRODH; EC 1.5.99.8) uses a flavin adenine dinucleotide (FAD) cofactor as an electron
acceptor to remove two electrons from proline, rendering the intermediate ∆1-pyrroline-5carboxylate (P5C). P5C then undergoes a non-enzymatic hydrolysis, which opens the
ring structure and generates γ-glutamate semialdehyde (GSA). Pyrroline-5-carboxylate
dehydrogenase (P5CDH; EC 1.5.1.12) next pulls off two additional electrons from GSA
using nicotinamide adenine dinucleotide (NAD+) to complete the conversion of proline to
glutamate [12].
The PRODH and P5CDH enzymes involved in the oxidation of proline are highly
conserved in both eukaryotes and prokaryotes, but differ in whether they are fused into a
bifunctional enzyme called proline utilization A (PutA).

As reviewed by Tanner,

PRODH enzymes can be divided into three branches [13]. One branch consists of
monofunctional enzymes, where the PRODH and P5CDH domains are found as separate
enzymes. The other two branches have the PRODH and P5CDH domains on a single
PutA polypeptide [13]. Originally it was thought that all prokaryotes contain bifunctional
PutAs, and that all eukaryotes contain monofunctional enzymes. However, it is now
known that Gram-positive bacteria contain monofunctional enzymes, thus limiting PutAs
to Gram-negative bacteria [14].
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Figure 1- Reactions of the proline metabolic pathway. In the catabolic pathway,
proline is converted to glutamate via a four electron oxidation process. Proline
dehydrogenase (PRODH) performs the first oxidative step, resulting in the intermediate
pyrroline-5-carboxylate (P5C).
P5C is subsequently hydrolyzed to glutamic
semialdehyde (GSA), which is then further oxidized by P5C dehydrogenase (P5CDH) to
generate glutamate. In Gram-negative bacteria, PRODH and P5CDH are fused together
on a bifunctional enzyme called proline utilization A (PutA). Proline anabolism begins
with phosphorylation of glutamate by γ-glutamyl kinase (GK) to generate γ-glutamyl
phosphate (gamma-GP). gamma-GP is reduced by γ-glutamyl phosphate reductase (GPR)
to GSA , which cyclizes to form P5C. P5C is then reduced to proline via pyrroline-5carboxylate reductase (P5CR). In higher eukaryotes such as plants and animals, GPR and
GK are fused together in the bifunctional enzyme pyrroline-5-carboxylate synthase
(P5CS).
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Figure 2 summarizes the domain organization of PRODH and P5CDH enzymes.
Monofunctional PRODHs typically are 200-540 amino acid residues in length, while
monofunctional P5CDHs are composed of 400-600 residues. Thermus thermophilus
PRODH and P5CDH are currently the only structures of monofunctional enzymes that
have been solved (PDB IDs: 2G37, 2EKG, 2BHP, 2BJA) [14-16]. PutAs consist of
1000-1350 residues with the P5CDH domain linked to the C-terminal end of the PRODH
domain [13]. The two branches of PutA enzymes are distinguished by whether or not
PutA also contains an N-terminal ribbon-helix-helix (RHH) DNA binding domain. PutAs
that contain a DNA binding domain are trifunctional and are generally longer
polypeptides than PutAs that lack a DNA binding domain [17-19].

Figure 2- Domain mapping of PRODH and P5CDH from E. coli (EcPutA), B.
japonicum (BjPutA), and T. thermophilus. In PutAs, the PRODH and P5CDH domains
are connected by a linker region (L). Trifunctional PutAs such as EcPutA also have a
DNA binding domain (D). TtPRODH and TtP5CDH are separate enzymes
(monofunctional) in the Gram-positive bacteria, T. thermophilus.
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Trifunctional PutAs act as transcriptional repressors—when cellular proline is scarce,
PutA binds DNA and represses expression of the putA and putP (Na+/proline transporter)
genes [20, 21].

Regulation of PutA is achieved through a functional switching

mechanism, where the redox state of flavin determines whether PutA is bound to the
DNA and acts as a transcriptional repressor or is peripherally bound to the membrane
where it efficiently catabolizes proline [22].
Recently, the first crystal structure of a complete PutA protein (Bradyrhizobium
japonicum) was solved by Tanner’s group (PDB ID: 3HAZ). Previously, the only
structures available for PutA were of the isolated PRODH and DNA binding domains.
The PRODH domain structure was solved for PutA from Escherichia coli (PDB IDs:
1K87, 1TJ2, ITIW, 1TJ0, 3ITG) [23-26], and the DNA binding domain of PutA was
solved by solution NMR (Pseudomonas putida) and X-ray diffraction (E. coli) (PDB IDs:
2JXG, 2GPE, 2RBF) [27-29]. These structures show that the PRODH domain is a
conserved β8α8-barrel, while the P5CDH domain contains a well conserved Rossmann
fold domain. The evolutionary divergence from bifunctional PutA to monofunctional
PRODH and P5CDH is of interest due to substrate channeling between the active sites in
bifunctional PutA. Substrate channeling between monofunctional enzymes would
necessitate functional PRODH-P5CDH interactions, which have not yet been explored
and are the focus of Chapter 2 in this thesis.
Proline biosynthesis
Proline biosynthesis from glutamate involves three enzymatic steps (Figure 1).
The initial two steps are catalyzed by γ-glutamyl kinase (GK; EC 2.7.2.11) and γglutamyl phosphate reductase (GPR; EC 1.2.1.41). GK uses adenosine-5’-triphosphate
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(ATP) to generate γ-glutamyl phosphate, which is subsequently reduced by GPR using
nicotinamide adenine dinucleotide phosphate (NADPH) to produce GSA [12]. GSA next
cyclizes to P5C, which is a crossroads intermediate that, in principle, can be converted
not only to proline, but also to ornithine or back to glutamate via P5CDH [12]. The
reduction of P5C to proline is catalyzed by P5C reductase (P5CR; EC 1.5.1.2), while the
production of ornithine from P5C requires ornithine aminotransferase (OAT; EC
2.6.1.13), an enzyme that is important for balancing cellular nitrogen levels [12].
In bacteria and lower eukaryotes such as yeast, GK and GPR are discrete
monofunctional enzymes. In animals and plants, the GK and GPR domains are fused
together into the bifunctional enzyme P5C synthase (P5CS) (Figure 3). The GK and
GPR domains are well conserved in lower eukaryotes and bacteria. The GK domain is
normally between 250-450 residues in length with an N-terminal amino acid kinase
(AAK) domain. In bacteria, GK contains a C-terminal pseudo uridine synthase and
archaeosine-specific transglycosylase (PUA) domain, which has no known function [30].
It has been suggested, however, that the PUA domain may enable bacterial GK to have a
gene regulatory role [31].

The structures of GK enzymes from E. coli and

Campylobacter jejuni have been solved (PDB IDs: 2J5T, 2AKO) [32]. E. coli GK is
composed of an N-terminal catalytic domain made up of eight nearly parallel β-sheets
sandwiched by two layers of three and four α-helices. It is connected by a linker region
to the PUA domain, which contains a distinctive β sandwich [32].
GPR typically contains 400-500 residues and consists of an N-terminal Rossmann
fold domain for NADPH binding, a catalytic domain, and an oligomerization domain at
the C-terminus [33]. The X-ray crystal structure of GPR from Thermotoga maritima
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Figure 3- Domain mapping of monofunctional γ-glutamyl phosphate reductase
(EcGPR) and γ-glutamyl kinase (EcGK) enzymes from E. coli and bifunctional
pyrroline-5-carboxylate synthase (P5CS) from Homo sapiens. M, putative
mitochondrial signaling peptide, BD, binding domain for glutamate and ATP, O,
oligomerization domain, and PUA, pseudo uridine synthase and archaeosine-specific
transglycosylase domain with no known function in EcGK.

reveals that the catalytic domain has an α/β architecture with a five-stranded parallel βsheet (PDB ID: 1O20) [33]. To date, no complete structure of bifunctional P5CS has
been reported. However, the structure of the isolated GPR domain (PDB ID: 2H5G;
unpublished) from human P5CS is available. The last enzyme of the proline biosynthetic
pathway, P5CR, ranges from 400-500 residues in length and has a conserved N-terminal
Rossmann fold for NADPH binding. Several crystal structures of P5CR have been
determined including the human form (PDB ID: 2GRA) [34]. Human P5CR has an active
site cleft made of an 8-stranded β-sheet sandwiched by α-helices on either side and
oligomerizes to form a decameric structure of dimers [34].
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INTERMEDIATES OF PROLINE METABOLISM
The P5C/GSA and γ–glutamyl phosphate intermediates of proline metabolism are
appreciably labile and reactive. Figure 4 shows examples of undesirable fates that can
occur with these intermediates. The instability of the intermediates implies substrate
channeling may be important for maintaining efficient proline metabolic flux. The
intermediate shared by the catabolic and biosynthetic pathways, P5C/GSA, has been
shown to inhibit other enzymes, react with metabolites, and act as a signaling molecule.
GSA has been reported to inhibit glucosamine-6-phosphate synthase from E. coli,
cytidine 5’-triphosphate synthase, and the amidotransferase domain of carbamoyl
phosphate synthetase [35-37]. Additionally, P5C forms adducts with other metabolites
such as pyruvic acid, oxaloacetic acid, and acetoacetic acid [38]. P5C can also react with
pyridoxal phosphate in patients with type II hyperprolinemia.

Figure 4- Side reactions of intermediates pyrroline-5-carboxylate (P5C) and γglutamyl phosphate (γ-GP). (A) P5C can deactivate pyridoxal phosphate by forming an
adduct, resulting in vitamin B6 deficiency in individuals with hyperprolinemia type II.
(B) γ-GP can cyclize and dephosphorylate to form 5-oxoproline, which is suggested to be
a neurotoxin in rats.
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Type II hyperprolinemia is characterized by elevated plasma levels of P5C/GSA due to
deficient P5CDH activity [39]. The high levels of P5C/GSA generates inactive adducts
with pyridoxal phosphate, leading to lower amounts of functional vitamin B6 in patients
(Figure 4) [38]. P5C also acts as a signaling molecule in eukaryotes and is thought to
induce apoptosis by increasing intracellular reactive oxygen species [40, 41]. Altogether,
it seems that controlling levels of free P5C/GSA would be beneficial.
The reactive intermediate in proline biosynthesis is γ–glutamyl-phosphate. The
carbonyl phosphate group is susceptible to nucleophilic attack, resulting in the
spontaneous cyclization of γ–glutamyl-phosphate into 5-oxoproline as shown in Figure 4
[42, 43]. It has been suggested that 5-oxoproline is a neurotoxin. Interstitial injection of
5-oxoproline into rats produces behavioral and neuropathological effects that resemble
Huntington’s disease [44, 45].

The instability of γ–glutamyl phosphate seems to

necessitate its channeling between GK and GPR during proline biosynthesis.

OVERVIEW OF SUBSTRATE CHANNELING
Rationale for substrate channeling
Substrate channeling is a phenomenon where the product of one reaction is
transported to a second active site without equilibrating into bulk solvent [46]. Three
mechanisms of substrate channeling have been defined, two of which are reviewed by
Miles et al. [47]. The most common form of substrate channeling occurs when a cavity
exists within a protein that sequesters the intermediate from solvent, allowing for a means
of travel between active sites [47]. To date, several enzymes are known to utilize these
intramolecular tunnels, with the classic example being tryptophan synthase [48]. The
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second form of channeling does not use intramolecular cavities; rather, electrostatic
residues on the surface of the enzyme guide the intermediate from the first active site to
the second active site [47].

Dihydrofolate reductase-thymidylate synthase complex

stands as the common example for this form of channeling [49]. A third form of
channeling exists in protein complexes such as pyruvate dehydrogenase, which uses
cofactor lipoic acid to transfer substrate to multiple active sites using a swinging arm
[50].
Substrate channeling has been proposed to be advantageous in the cellular
environment for several reasons, as outlined by Ovadi and others [46, 51]. First and
foremost it increases the efficiency of coupled reactions both by preventing the loss of
intermediates to diffusion and by decreasing transit time between active sites. This allows
the steady-state flux through the coupled steps to be attained more rapidly [46].
Secondly, it prevents labile intermediates from decaying and reacting with other
metabolites or enzymes within the cell [46]. Third, channeling segregates intermediates
that may require a specific environment (e.g., pH) to retain structure or reactivity.
Channels can provide an environment that facilitates an equilibrium step that normally
would be unfavorable in the bulk solution. Finally, channeling limits intermediates from
being siphoned out into competing reactions or pathways [46].
All of the benefits listed above are not necessarily relevant for every channeling
system. In the proline catabolic pathway, channeling of P5C/GSA may be most critical
for making the hydrolysis of P5C to GSA more favorable at physiological pH values. The
P5C/GSA equilibrium is highly pH dependent [35]. GSA is favored only below pH 6.5
due to protonation of the pyrrolinium ring, which facilitates the hydrolysis of P5C to
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GSA. Thus, one benefit of channeling between PRODH and P5CDH would be to
increase the pKa of the pyrrolinium species above pH 6.6, making the hydrolysis of P5C
to GSA more favorable at physiological pH conditions. If we only consider the P5C/GSA
hydrolysis step, substrate channeling is likely more critical for the proline catabolic
pathway than for proline biosynthesis, since P5C formation is favored at physiological
pH. In the proline biosynthetic pathway, protecting the highly labile γ–glutamyl
phosphate would be a clear benefit of substrate channeling between GK and GPR.

KINETIC APPROACHES TO TEST FOR SUBSTRATE CHANNELING
Different strategies have been devised to examine whether channeling occurs
between enzymes. Before reviewing the evidence for substrate channeling in proline
metabolism, a short description of various experimental methods is described here.
Transient time estimation
A common strategy to test for channeling is to evaluate whether there is a lag time in
reaching steady-state formation of the final product in a coupled assay. Figure 5 shows
substrate (S) being converted to the final product (P) via the coupled action of two
enzymes (E1 and E2). The lag time or transient time, Tau, is the time preceding the buildup to steady-state formation of the final product using the substrate of the first enzyme
[52]. If no channeling occurs, Tau should be equal to the ratio of Km/Vmax of the second
enzyme. If the observed lag time is shorter than the Km/Vmax ratio, then it infers that the
intermediate is transferred between the enzymes, E1 and E2. The extent of the observed
lag time may vary among different channeling systems with a shorter transient time being
interpreted as more efficient transfer or channeling [53]. Along with steady-state assays,
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pre-steady state measurements can also be made to evaluate the lag time prior to product
formation.
Trapping the intermediate
The effect of a reagent that specifically traps the intermediate species (I, Figure 5)
on the kinetics of product formation can also be used to evaluate channeling. For
example, o-aminobenzaldehyde (o-AB) which reacts with P5C to form a yellow complex
can be used as a trapping agent for the PRODH and P5CDH coupled reaction. o-AB
would be anticipated to decrease the overall rate of glutamate formation if no channeling
occurs, while in a channeling system o-AB would have a negligible effect on the reaction
kinetics. Using a third enzyme that competes with E2 for the intermediate can also be an
effective strategy to test for substrate channeling.
Inactive mutants
Another useful tool is to generate active site mutants of the two enzymes being
studied (Figure 5B). In the case of suspected channeling partners, an active site mutant
(e.g., E2) would be expected to compete with its native counterpart for interaction with
the cognate enzyme (E1). If channeling occurs, adding the inactive E2 mutant in amounts
excess to that of native E2 would decrease product formation. If no channeling occurs,
adding the inactive E2 mutant to the coupled enzyme assay would have no effect on the
rate of product formation. This strategy was effectively used to rule out channeling
between aspartate aminotransferase (AAT) and malate dehydrogenase (MDH) [54].
If the channeling involves two enzyme active sites that are covalently linked,
active site mutants can be used to generate a non-channeling control. Figure 5C illustrates
that combining active site mutants of E1 and E2 creates a mixture of monofunctional
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enzyme variants that can only generate product via a diffusion mechanism. The transient
times of the native enzyme and the mixed enzyme variants can then be compared to
distinguish between channeling and non-channeling mechanisms. This strategy was used
recently to demonstrate channeling in bifunctional PutA [23].

Figure 5- Strategies for examining substrate channeling. (A) Transient time analysis
of a coupled reaction involving two enzymes, E1 and E2, which convert substrate A into
product C. A trapping agent can also be used to test whether intermediate B is released
into bulk solvent during the reaction. (B) Inactivation of one of the enzyme pairs by sitedirected mutagenesis. If channeling occurs, adding inactive E2 would disrupt the active
E1-E2 complex resulting in lower steady-state activity. (C) Testing channeling in
bifunctional enzymes. Inactivation of the individual domains results in monofunctional
variants that can only catalyze the coupled reaction via a diffusion mechanism. The
mixture of monofunctional variants is thus a non-channeling control.
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Designing fusion proteins
Two active sites that are in close proximity can sometimes exhibit kinetic
behavior that resembles direct channeling [55]. One strategy for distinguishing between
active channeling and proximity effects is to change the relative orientation of two active
sites, which is important for interacting enzymes [56]. A polypeptide linker can be
engineered to covalently link the two enzymes with various degrees of flexibility and in
different orientations [55]. If the enzymes are truly channeling, changes in the orientation
of the active sites will have a dramatic effect on the kinetics of production formation.

CHANNELING OF P5C/GSA
The oxidation of proline to glutamate is catalyzed in consecutive reactions by
PRODH and P5CDH (Figure 1). Avoiding release of P5C/GSA into bulk solvent during
proline oxidation may be beneficial due to the chemical properties of P5C/GSA as
discussed in the previous section. Evidence for channeling P5C/GSA has recently been
shown for bifunctional PutA from B. japonicum (BjPutA). Srivastava et al reported a 2.1
Å resolution crystal structure of BjPutA (999-residue polypeptide) that reveals an interior
channel connecting the PRODH and P5CDH active sites (PDB ID: 3HAZ) [23]. Figure 6
shows a structural model of BjPutA, which purifies as a homodimer. Both PRODH and
P5CDH domains contribute to the formation of the channel, with the two active sites
separated by a distance of 41 Å. The connecting channel appears to start at the si face of
the isoalloxazine ring of FAD and end at the catalytic cysteine (Cys792) of the P5CDH
domain (Figure 6). Within the channel, the central cavity is lined by fifteen basic residues
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FAD
Isoalloxazine
-flap
Catalytic
Arg456

Catalytic
Cys792

NAD+

Figure 6- Structure of dimeric BjPutA shown in ribbon representation. The PRODH
domain (red) and the P5CDH domain (orange) of each protomer are connected by a
linker region (green). Active site residues (Arg456, Cys792), FAD and NAD+ are
displayed as sticks. -flap of each protomer is colored as magenta. The substrate channel
of each BjPutA protomer is shown as blue surface. This model was made using PyMol
[57] and PDB ID: 3HAZ.
(Lys and Arg) and seventeen acidic residues (Glu and Asp), imparting a hydrophilic
nature to the channel. Each of the PutA protomers has an individual channel connecting
PRODH and P5CDH active sites.
Interestingly, the dimeric structure of BjPutA seems to be critical for sealing the
channel and minimizing access to bulk solvent. A beta-flap protrudes from the P5CDH
domain (β strands, residues 628-646, 977-989) from one protomer and forms
intermolecular interactions with the P5CDH domain of the second protomer (Figure 6).
This β-flap is structurally conserved in Thermus thermophilus P5CDH (PDB ID 1UZB,
residues 163-174,506-516) as well as a class I aldehyde dehydrogenase isolated from
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sheep liver (PDB ID: 1BXS, residues 147-159, 486-498) [58] [16]. Thus, in BjPutA, the
β-flap not only helps stabilize dimer formation but is also important for sealing the
central cavity.
Along with these structural features of channeling, kinetic evidence for
channeling was also reported for BjPutA by Srivastava et al. Different experiments have
provided strong evidence for channeling. First, the amount of P5C released into bulk
solvent was estimated using o-aminobenzaldehyde (o-AB) as a trapping agent. P5C and
o-AB react to form a yellow complex that can be monitored at 443 nm [59]. In the
absence of NAD+, the P5CDH domain is inactive and leads to significant release of P5C
into the bulk solvent, as detected by the yellow complex formation. In the presence of
NAD+, however, the P5CDH domain is active, resulting in significantly lower o-AB-P5C
complex formation, as the majority of P5C is converted into glutamate [23]. The apparent
fraction of P5C that is channeled in BjPutA from PRODH to P5CDH was estimated to be
0.7 by these measurements.
Substrate channeling in BjPutA was also examined by estimating the transient
time to reach steady-state turnover of the second enzyme, P5CDH, using proline as a
substrate [23, 60, 61]. With native BjPutA, steady-state formation of NADH (product of
the P5CDH reaction) occurred without any apparent lag time [23]. The absence of a lag
time in the approach to steady-state indicates substrate channeling. A non-channeling
control was also analyzed using active site mutants of BjPutA that lack PRODH
(R456M) and P5CDH (C792A) activity [23]. The R456M mutation inactivates PRODH
but does not impair P5CDH activity, whereas the C792A mutation inactivates P5CDH
but does not impair PRODH activity. The mixture of these monofunctional variants was
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used as a non-channeling control as described above. In this non-channeling control, P5C
formed by the C792A variant must diffuse out into bulk solvent and bind to the R456M
variant before NADH is formed. In the assays with the non-channeling variants, a lag
time of about seven minutes for NADH formation was observed [23]. The observed lag
time was similar to the theoretical Tau value calculated from the independent PRODH
activity and P5CDH kinetic parameters. An example of these steady-state assays is
shown in Figure 7. Figure 7 illustrates the clear difference in the kinetic behavior of
native BjPutA and the non-channeling control. With native BjPutA, NADH formation is
observed without a lag time, while with the mixed variants a lag time of around 6.5
minutes is observed. The results from these assays are consistent with a substrate
channeling mechanism in BjPutA. Kinetic profiles of native BjPutA and the mixed
variants were also compared by rapid-reaction kinetics under anaerobic, single-turnover
conditions. Rapid mixing of native BjPutA and proline generated NADH with no
apparent lag time. For the non-channeling variants, a 10 s lag time for NADH formation
was observed after mixing the enzymes with proline. These results show native BjPutA
efficiently channels P5C/GSA.
Evidence for channeling in PutA has also been reported from Salmonella
typhimurium PutA (StPutA). Similar to EcPutA, StPutA contains the N-terminal DNA
binding domain and is thus trifunctional. Maloy et al demonstrated that the P5CDH
domain shows a 14-fold greater steady-state production of NADH using P5C generated
endogenously from proline by PRODH, as compared to exogenously added P5C [63]. In
addition, they showed exogenous P5C was unable to compete against endogenous P5C.
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Figure 7- Example of transient time analysis of BjPutA. Steady-state formation of
NADH using proline as a substrate by native BjPutA (solid black curve) and an
equimolar mixture of monofunctional variants R456M and C792A (solid grey curve).
The mixture of the monofunctional variants serves as a non-channeling control. The
dotted line represents the extrapolation used for estimating the lag-time. Native BjPutA
shows no apparent lag in NADH formation, while a lag time of about 6.5 min is observed
for the non-channeling control. The dashed line overlaying the grey curve of the nonchanneling control reaction was simulated using the kinetic parameters of PRODH and
P5CDH as described previously and the following equation: [NADH] = v1t + (v1/v2)Km(ev2t/Km
- 1) [62]. Assays were performed at pH 7.5.

Despite two-fold excess of exogenous P5C, 86 % of glutamate was produced from
endogenous P5C. Due to a lack of structural information on trifunctional PutAs, it is not
clear whether a channel similar to that characterized in BjPutA exists. Future structural
and kinetic experiments will need to be performed to fully address the channeling
mechanism in trifunctional PutAs.

CHANNELING OF GAMMA-GLUTAMYL PHOSPHATE
As mentioned previously, channeling of the intermediate γ-glutamyl phosphate
would be beneficial because of its instability. Channeling of γ-glutamyl phosphate is also
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implicated by the fusion of GK and GPR in bifunctional P5CS. Kinetically speaking, data
has existed for over forty years suggesting that a complex forms between bacterial GK
and GPR in order to conceal γ-glutamyl-phosphate from solvent [64, 65]. A typical assay
to measure GK activity is to add hydroxylamine along with the substrates, glutamate and
ATP. Hydroxylamine reacts with the product γ-glutamyl phosphate to make γ-glutamyl
hydroxamate, which can be measured at 535 nm [64]. Multiple groups have documented
that GK activity is dependent on the presence of GPR. GK is inactive or exhibits very
low activity in the absence of GPR, suggesting GPR is required for GK activity [42, 43,
64, 66, 67]. It was found that a 10:1 GPR:GK ratio was necessary to obtain maximal GK
activity, indicating that a GK/GPR complex forms with excess GPR [66]. To test for a
complex, Smith et al. tried incubating different ratios of bacterial GK and GPR, then
looked for co-elution of the enzymes by chromatography [66]. Both proteins eluted
separately meaning either a complex does not form or complex formation is transient and
is dependent on substrate binding. Other work suggesting a GK-GPR complex includes
assays which contained GK and GPR, but lacked NADPH, the cofactor necessary for
GPR activity [43]. In this case the GPR enzyme was inactive, but it still activated GK.
GK has also been shown to be activated by incubation with GPR mutants, further
demonstrating that GK activation by GPR does not require GPR activity [68]. Other
experiments that have explored GK/GPR interactions include Chen et al, who created a
mutant GK/GPR fusion protein that was able to over-produce proline, making the host E.
coli strain more resistant to osmotic stress [69]. While this work does not support
channeling directly, it does show that enhancing the proximity of two active sites can
significantly increase the efficiency of a metabolic pathway [69].
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Structural data supporting channeling is not directly available for GK and GPR
enzymes [70]. Figure 8 shows the individual structures of E. coli GK (EcGK) and T.
maritima GPR (TtGPR). Marco-Marin et al modeled a possible interaction between
monofunctional GK and GPR, showing GPR in both an open and closed conformation,
depending on the binding status of the substrate [32]. The model shows a tetrameric form

Figure 8- Structures of GPR from T. maritima (TmGPR) and GK from E. coli
(EcGK). EcGK is shown as a dimer with one monomer shown in surface representation
and the other monomer as a ribbon cartoon illustration. Glutamate is shown as spheres in
the substrate binding pocket, which is solvent accessible. Only one monomer of GPR
(open conformation) is shown, which contains three domains: NADPH binding domain
(yellow), catalytic domain (blue) with the catalytic cysteine shown in spheres, and the
oligomerization domain (black). The solvent-exposed glutamate binding pocket of GK
suggests that the γ-glutamyl phosphate intermediate would be accessible to GPR in a
potential GK-GPR complex. A GK-GPR complex in which the catalytic domain of GPR
is aligned with the glutamate binding pocket of GK has been proposed and modeled by
Marco-Marin et al [32]. Models shown here were made using PyMol [57] and PDB IDs:
2J5T (EcGK) and 1O20 (TmGPR).
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of GK from E. coli complexed with a dimer of GPR from T. maritime [32]. In solving
the crystal structure EcGK, Marco-Marin et al. noted that GK was well suited for
channeling [32]. They suggested that channeling is possible if the GK and GPR active
sites are positioned so that the active site cysteine of GPR is able to react with γ-glutamyl
phosphate while still bound at the GK active site. A complex as described would allow
for a favorable environment and timely transfer of γ-glutamyl-phosphate to the second
active site thereby preventing cyclization to 5-oxoproline [32]. Additionally it has been
suggested that leucine zipper motifs found in the GK and GPR domains of plants, as well
as the GK and GPR enzymes of some bacteria are evidence for a functional complex
[71]. The leucine zipper of plant P5CS may help with oligomerization or it may be an
artifact of evolution. Several domain swapping experiments have shown that leucine
zippers mediate protein-protein dimerization in eukaryotic and prokaryotic enzymes.
Thus, the leucine zippers in bacterial GK and GPR enzymes and plant P5CS may support
a possible channeling complex [72].

SUMMARY
Proline metabolism has become a very important area of study due to its
involvement in many different cellular processes from maintaining redox balance to
countering environmental stress. As described in this review, substrate channeling is a
relevant mechanism in proline metabolism for translocating important intermediates
between active sites. Rational for substrate channeling in proline metabolism is two-fold.
First, the equilibrium for the hydrolysis of P5C to GSA is unfavorable at physiological
pH indicating channeling may be necessary to increase the overall conversion efficiency
of proline into glutamate. Second, P5C/GSA and γ-glutamyl-phosphate are reactive and
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labile intermediates. Channeling of these intermediates would protect against the
formation of unwanted products, such as 5-oxoproline from γ-glutamyl-phosphate.
Future kinetic and structural studies are important for understanding the
mechanisms of substrate channeling in proline metabolism.

In proline catabolism,

BjPutA provides structural and kinetic data supporting channeling, but more work needs
to be done on trifunctional and monofunctional enzymes. Substrate channeling in PutAs
suggests that bacteria have evolved a strategy to limit the availability of P5C to other
competing pathways. P5C is at the crossroads of important metabolic pathways, which
include proline oxidation, urea cycle, TCA cycle via glutamate, and the proline
biosynthetic pathway [73]. Substrate channeling by PutA may help maintain flux through
the proline oxidative pathway, which would be especially important under poor nutrient
conditions in cells starved for nitrogen and glutamate and other downstream products
such as α–ketoglutarate. Whether P5C/GSA is channeled in Gram-positive bacteria and
eukaryotes is not yet known. Studies of PRODH-P5CDH coupled kinetics and potential
PRODH-P5CDH interactions are needed to address channeling between monofunctional
PRODH and P5CDH enzymes. In proline biosynthesis, evidence for interactions between
monofunctional GPR and GK has been reported, but structural evidence for channeling in
bifunctional P5CS is currently not available. Although channeling interactions between
GK and GPR seem likely and are supported by several studies, additional work is
required to define the channeling pathway and mechanisms in proline biosynthesis. To
date, a full-length structure of P5CS has not been reported. Solving a crystal structure of
P5CS would be a significant step toward understanding channeling of γ-glutamyl
phosphate. Not only would a complete structure of P5CS act as a template for modeling
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the interaction between monofunctional GK and GPR, but it could also be used to
identify cavities within the protein that may act as channels for transporting γ-glutamyl
phosphate between active sites.
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CHAPTER 2
Investigation of substrate
channeling between
monofunctional PRODH and P5CDH
enzymes of Thermus thermophilus
Note: The results discussed in this chapter are being prepared for manuscript
“Evidence for substrate channeling in monofunctional proline metabolic enzymes of
Thermus thermophilus.” Sanyal N, Tanner JJ, Becker DF. Manuscript in preparation.
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INTRODUCTION
The oxidative conversion of proline to glutamate involves two enzymes, a flavin
dependent proline dehydrogenase (PRODH) and a NAD+-dependent ∆1-pyrroline-5carboxylate (P5C) dehydrogenase (P5CDH). PRODH and P5CDH help organisms
respond to changes in the nutritional environment by initiating the breakdown of proline
as a source for nitrogen, carbon, and energy [1-6] (Scheme 1). In Gram negative bacteria
such Escherichia coli and Bradyrhizobium japonicum, PRODH and P5CDH catalytic
domains are fused into one polypeptide known as proline utilization A or PutA [7].
P5C and γ-glutamate semialdehyde (GSA) are the intermediates of the proline and
ornithine metabolic pathways [8]. The interconversion of P5C and GSA occurs via a nonenzymatic pH-dependent hydrolysis. P5C/GSA are appreciably labile and have been
shown to react with metabolites, inhibit enzymes, and act as signaling molecules. GSA
has been reported to inhibit glucosamine-6-phosphate synthase from E. coli, cytidine 5’triphosphate synthase, and the amidotransferase domain of carbamoyl phosphate
synthetase [9-11].

Scheme 1- An overview of the two-step oxidation of proline by proline dehydrogenase
(PRODH) and ∆1-pyrroline-5-carboxylate dehydrogenase (P5CDH). The physiological
electron acceptor for PRODH during catalytic turnover is assumed to be a membrane
bound electron carrier such as ubiquinone. Figure is adapted from [15].
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Additionally, P5C forms adducts with other metabolites such as pyruvic acid,
oxaloacetic acid, and acetoacetic acid [12]. P5C can also react with pyridoxal phosphate
in patients with type II hyperprolinemia. The high levels of P5C/GSA generates inactive
adducts with pyridoxal phosphate, leading to lower amounts of functional vitamin B6 in
patients [12]. P5C also acts as a signaling molecule in eukaryotes and is thought to
induce apoptosis by increasing intracellular reactive oxygen species [13, 14].
Altogether, it seems that controlling the levels of free P5C/GSA would be
beneficial for the cell. The instability of the intermediates and competition from proline
biosynthetic and ornithine metabolic pathways implies substrate channeling may be
important for maintaining efficient proline catabolic flux. Substrate channeling is a
phenomenon where the product of one reaction is transported to a second active site
without equilibrating into bulk solvent [16].
Our

previous

study

using

enzyme

kinetic

measurements

and

X-ray

crystallography in collaboration with Dr. John Tanner’s laboratory (University of
Missouri-Columbia) has shown that the PRODH and P5CDH domains of bifunctional
PutA (BjPutA) from Gram-negative Bradyrhizobium japonicum are connected by a large,
elongated channel [15]. Kinetic data have shown that substrate channeling in BjPutA
facilitates product formation by decreasing the transient time for glutamate production.
Using small-angle X-ray scattering (SAXS), similar occurrence of substrate channeling
has also been proposed in PutA from Escherichia coli [17]. Thus, a general feature of
PutA’s may be the sequestering of the P5C/GSA intermediate and efficient transfer of
P5C/GSA from PRODH to the P5CDH active site without equilibrating with the contents
of the cytoplasm.
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The 4e- oxidation of proline to glutamate by PRODH and P5CDH enzymes is
highly conserved in all domains of life [7]. However, unlike Gram-negative bacteria,
organisms

such

as

Gram-positive

bacteria

and

eukaryotes

express

separate

monofunctional PRODH and P5CDH enzymes (Figure 1). Table 1 shows that
intracellular proline concentrations are within an order of magnitude in various
representative organisms.
It is thus anticipated that the oxidation of proline by PRODH would lead to
significant amounts of P5C/GSA formation and, as mentioned above lead to deleterious
effects such as inhibition of nucleoside synthesis, PLP-dependent enzymes and other
metabolic processes impacted by P5C/GSA. To prevent substantial build-up of P5C/GSA
in these organisms, the expression and activity levels of PRODH and P5CDH would need
to be highly coordinated. As part of the mechanism by which organisms regulate proline
metabolic flux, it is feasible that PRODH and P5CDH form a bienzyme complex. To
date, however, no studies have been performed to test substrate channeling and potential
interactions between monofunctional PRODH and P5CDH enzymes. It is not known
whether monofunctional PRODH and P5CDH enzymes physically interact to form an
internal cavity and to facilitate P5C/GSA channeling similar to bifunctional PutAs.
The main objective of this study is to investigate substrate channeling between
monofunctional PRODH and P5CDH from Thermus thermophilus. PRODH from
Thermus thermophilus (TtPRODH) was previously characterized and shown to be a 35
kDa flavoprotein containing a triosephosphate isomerase (TIM) barrel (β8α8) catalytic
domain [18, 19]. TtPRODH shares the catalytic β8α8 fold domain previously reported for
bifunctional PutA (White, Krishnan et al. 2007). P5CDH from Thermus thermophilus
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Figure 1- Phylogenetic tree representation of proline oxidative enzymes. Branch 1
and Branch 2 organisms, most of which are Gram-negative bacteria, encode for the
bifunctional enzyme, PutA. Branch 3B displays organisms from Archaea and bacteria
that express monofunctional PRODH and P5CDH. Examples of such organisms include
Thermus thermophilus, Deinococcus radiodurans, and Staphylococcus aureus. Branch
3A includes all eukaryotic organisms. Figure from [7] with permission from source.
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Table 1- Intracellular proline concentrations in various organisms under nonstressed conditions.
Intracellular Proline

Source

27.8 mM

(Chen, Cao et al. 2006) [51]

0.39 mM

(Bennett, Kimball et al. 2009) [52]

Salmonella typhimurium

0.11 mM

Bacillus subtilis

16.4 mM

Thermus thermophilus

8.78 mM

(Csonka 1988) [53]
(Whatmore, Chudek et al. 1990;
Roesser and Muller 2001) [54, 55]
(Kosuge and Hoshino 1998) [56]

3.15 mM

(Chen, Wanduragala et al. 2006) [57]

2.9 mM

(Morita, Nakamori et al. 2003) [58]

0.1 – 0.26 mM

(Jaksic, Wagner et al. 1990) [59]

Organism

Escherichia coli

Saccharomyces cerevisiae
Human plasma

(TtP5CDH) has also been previously characterized and is a 57kDa protein that exists as
hexamer in crystal form [18, 19]. Because TtPRODH and TtP5CDH are the best
characterized pair of monofunctional enzymes in proline metabolism, they were chosen
for studying substrate channeling in vitro.
The main strategy for testing substrate channeling is adapted from the work of
Geck and Kirsch [20] and is illustrated in Figure 2. Using proline as a substrate, the
amount of NADH generated, which is equivalent to the amount of glutamate product, is
measured in assays using an equimolar mixture of TtPRODH andTtP5CDH. This coupled
assay is called a channeling assay. The experiment is carried out in the presence of
increasing amounts of catalytically inactive mutants of TtP5CDH or TtPRODH. In these
assays, evidence for channeling between TtPRODH and TtP5CDH is considered when
NADH formation decreases with increased amounts of the inactive mutant. For example,
if PRODH and P5CDH form a channeling complex, the addition of an excess amount of a
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P5CDH inactive mutant would compete with native P5CDH for binding to TtPRODH.
This would result in formation of a complex where the second enzyme is inactive and,
thus, the rate of the coupled proline to glutamate conversion would decrease (Figure 2).
Conversely,

inactive

mutants

of

TtPRODH

could

also

interfere

with

a

TtPRODH/TtP5CDH channeling complex and yield similar results. If substrate
channeling does not occur, the presence of the inactive mutant should not affect the rate
of NADH formation.

Figure 2- Strategy for testing substrate channeling between monofunctional
PRODH and P5CDH. E1 and E2 represent PRODH and P5CDH respectively. A, B and
C represent proline, P5C/GSA and glutamate, respectively.
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The strategy outlined in Figure 2 has been used previously to demonstrate
substrate channeling between muscle aldolase and fructose 1,6-bisphosphatase [21] and
between aspartokinase and aspartate semialdehyde dehydrogenase [22]. More frequently,
however, the above strategy has been used to rule out substrate channeling such as
between aspartate aminotransferase and malate dehydrogenase [20] and for methyl
erythritol phosphate biosynthetic enzymes IspDF and IspE [23].
Channeling of an intermediate requires some form of interaction between the pair
of enzymes, regardless of how transient or stable the interactions might be. Without
sufficient interactions between enzyme pairs, the intermediate is likely to quickly diffuse
into the bulk solvent. Hence, to support the kinetic studies on substrate channeling,
protein-protein interactions between TtPRODH and TtP5CDH were also investigated
using surface plasmon resonance (SPR). SPR is a sensitive and powerful tool for
detecting and measuring biomolecular interactions [24]. Properly designed SPR
experiments not only provide estimates of protein-protein binding affinities but also the
kinetic parameters of the binding event.
Substrate channeling has been demonstrated for PutA and other multifunctional
enzymes [25-27] and, individual enzymes proximally docked onto a scaffold [28, 29].
The scientific novelty of this study is the evidence for substrate channeling between two
separate enzymes.
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EXPERIMENTAL PROCEDURES
Materials
All chemicals and buffers were obtained from Sigma-Aldrich or Fisher Scientific
unless otherwise noted. DL-P5C was chemically synthesized from DL-hydroxylysine as
described previously by Williams and Frank and stored in 1M HCl at 4oC. [30]. D,L-P5C
contains

equimolar

concentration

of

D-P5C

and

L-P5C.

N-(Biotinoyl)-N'-

(iodoacetyl)ethylenediamine (BIAM) and dimethyl sulfoxide (DMSO) were obtained
from Molecular Probes. The streptavidin (SA) sensor chip and PD-10 desalting columns
were purchased from GE Healthcare. The molecular interaction between TtPRODH and
TtP5CDH was studied using a BIAcore 3000 (BIACORE AB, Uppsala, Sweden)
instrument maintained in the Molecular Interaction Core Facility at the University of
Nebraska Medical Center. Assays for enzymatic activities of PRODH and P5CDH were
carried out on a Cary-50 UV-Vis spectrophotometer (Varian) or Powerwave XS
Microplate reader (BioTek). Substrate channeling assays were carried out on a SF61DX2 stopped-flow spectrophotometer (TgK Scientific, UK). The TtP5CDH-pKA8H
construct and purified DrP5CDH inactive mutant (C325A) were generous gifts from Dr.
John Tanner at the University of Missouri-Columbia.
Constructs and site-directed mutagenesis
The TtPRODH and TtP5CDH genes were expressed from a pKA8H expression
vector as previously described [18, 19]. The PUT2 gene encoding P5CDH from
Saccharomyces cerevisiae (Put2p) was cloned into a pET14b expression vector (pET14bPUT2) as described in Chapter 3 of this thesis. Site-directed mutagenesis for active site
and surface mutations was performed using the GeneTailor mutagenesis kit (Invitrogen).
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The mutants generated in this study and the corresponding primers used for introducing
active site mutations are listed in Table 2.

The codon change for mutagenesis is

highlighted in bold letters. All mutations were confirmed by DNA sequencing.

Table 2 – List of primers used for site-directed mutagenesis

Mutation

Primer

Sequence

Forward primer

5’ acggcttccaggggcagaaggcctccgcggcga 3’

Reverse primer

5’ cttctgcccctggaagccgtaggcggagac 3’

Forward primer

5’ actggtacccctacctcaccatgatgatcgcggagag 3’

Reverse Primer

5’ ggtgaggtaggggtaccagtcccggccgtag 3’

Forward primer

5’ cctggacctggcttaccgttgcttcgtgctcgg 3’

Reverse primer

5’ aacggtaagccaggtccaggttcat 3’

Forward primer

5’ ttgagctcgtctgggccctttgcgggaagccct 3’

Reverse Primer

5’ a agggcccagacgagctcaaggagccccct 3’

Forward primer

5’ tcgagttccaaggccaaaaggcctctgccgctt 3’

Reverse Primer

5’ agaggcactttcgagttccaaggccaaaag 3’

TtP5CDH C322A

TtPRODH
R288M/R289M

TtPRODH S8C

TtPRODH A88C

Put2 C351A

Purification of TtPRODH and TtP5CDH enzymes
All proteins were expressed and purified from E. coli strain BL21(DE3) pLysS
with a N-terminal 6xHis tag using the pKA8H construct as described here. pKA8H
constructs for expressing wild-type TtPRODH, TtPRODH R288M/R289M, TtPRODH
S8C, TtPRODH A88C, wild-type TtP5CDH, and TtP5CDH C322A, and pET14b-PUT2
were transformed separately into E. coli BL21(DE3) pLysS. For enzyme expression and
purification, newly transformed cells were plated onto Luria-Bertani (LB) agar
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containing chloramphenicol (34 µg/ml) and ampicillin (50 µg/ml). Resulting colonies
were inoculated in 5 ml of LB broth containing the necessary antibiotics and grown to an
optical density at 600 nm (OD600) of 1.0. 1 ml of the LB culture was then used to
inoculate 1 L of LB Broth media containing chloramphenicol (34 µg/ml) and ampicillin
(50 µg/ml). The 1 L cultures were incubated at 37oC with shaking (250 rpm) until OD600
of 0.8 at which point protein expression was induced with 0.5 mM IPTG overnight at
20oC.
The overnight cultures were centrifuged at 6000 rpm for 20 min at 4 oC. The
resulting pellets were resuspended in a final 50 ml volume of binding buffer (20 mM
Tris, 5 mM imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) supplemented with protease
inhibitors (3 mM -amino-N-caproic acid, 0.3 mM phenyl methyl sulfonyl chloride, 1.2
µM leupeptin, 48 µM N-p-tosyl-L-phenyl alanine chloromethyl ketone, 78 µM N- p tosyl-L-lysine chloromethylketone). 1 mM FAD and 0.25% Triton-X 100 was
additionally supplemented for purification of wild-type TtPRODH and TtPRODH mutant
R288M/R289M. Cell suspensions were disrupted by sonication at 4oC for a total of 5 min
(5 sec pulse on, 15 sec pulse off, 40% power). The cell extract was centrifuged at 16000
rpm (4oC) for 60 min. The supernatant (50 ml) was passed through a 0.8 µm filter (VWR)
and applied to a Ni-NTA superflow (Qiagen) resin (25 ml bed volume in a 2.8 cm x 30
cm column) equilibrated with 1X binding buffer. Wash buffer (125 ml, 20 mM Tris, 60
mM imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) was then applied to the column
followed by elution buffer (20 mM Tris, 500 mM imidazole, 0.5 M NaCl, 10% glycerol,
pH 7.9) with a flow rate of 3 ml/min to elute His-tagged recombinant proteins. Fractions
from the elution step were then analyzed by SDS-PAGE and pooled. Pooled protein was
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then dialyzed into 50 mM Tris buffer (pH 8.0) containing 25 mM NaCl, 10% glycerol,
0.5 mM Tris (3-hydroxypropyl) phosphine (THP) and concentrated using an Amicon 30kDa cutoff filter (Millipore). The final concentration of purified protein was determined
using the BCA method and is expressed as concentration of monomer unless stated
otherwise [23]. The 6xHis tag was not removed after purification.

Measurement of PRODH and P5CDH activities
PRODH Activity
TtPRODH activity was measured at 25oC using Coenzyme Q1 (CoQ1) as the
terminal electron acceptor. For measurement of kinetic parameters for proline and CoQ1,
TtPRODH (0.5 μM) was mixed in 50 mM phosphate buffer at pH 8.0 with varying
proline (0-100 mM) and fixed CoQ1 concentrations (150 µM) or varying CoQ1 (0-300
M) and fixed proline concentrations (150 mM). Reaction progress was monitored by
following reduction of CoQ1 at 275 nm (ε= 13700 cm-1 M-1) using a 0.15 cm path length
on a Hi-Tech Scientific SF-61DX2 stopped-flow instrument at 25oC [31]. The kinetic
parameters Km and kcat were estimated by regression analysis of the initial reaction
velocity versus proline concentration using the Michaelis-Menten equation and
Lineweaver-Burk plot analysis [32].

Proline:dichlorophenolindophenol (DCPIP)

oxidoreductase assay was used for measurement of specific activity of TtPRODH in a 1ml reaction volume using Cary 100 and Cary 50 UV-visible spectrophotometers [33].
The DCPIP assay mixture contained 0.2 μM of TtPRODH enzyme, 0.27 mM phenazine
methosulfate, 75 μM DCPIP and 300 mM proline in 20 mM Tris at pH 8.0. The rate of
DCPIP reduction was measured at 595 nm (ε = 16100 cm-1 M-1) [33]. One unit of
PRODH is defined as the amount of enzyme that reduces 1 µmole of DCPIP per min.
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Test for the effect of TtP5CDH C322A and BSA on TtPRODH activity was done using
the proline:DCPIP oxidoreductase assay with 1 mM proline as substrate and 1 to 25 µM
concentrations of TtP5CDH C322A and BSA.
P5CDH Activity
P5CDH activity was measured by monitoring the formation of NADH at 340 nm
(ε = 6400 cm-1 M-1) at 25 °C. The assay buffer contained 50 mM potassium phosphate
(pH 7.5) and 25 mM NaCl. P5CDH enzyme concentration was 0.5 µM (30 g/ml) and
NAD+ concentration was 0.2 mM. Varying concentrations of L-P5C ranging from 1 to
300 µM were used. Initial rates were fitted to a Michaelis-Menten equation (equation
2.1).
[ ]
[ ]
Inhibition studies of P5CDH activity were carried out using the assays conditions
described above with increasing concentrations of proline (0-15 mM). Initial velocities
as function of P5C concentration at different proline concentrations were fitted to a
competitive inhibition model (equation 2.2) using SigmaPlot 12 Enzyme Kinetics
Module (Systat Inc.), where v is P5CDH velocity (µM/sec), [E] T is P5CDH concentration
(µM), kcat (sec-1) and Km (µM) are the Michaelis-Menten constants for P5CDH, [S] is LP5C concentration (µM), [I] is the proline concentration (µM) and KI is the competitive
inhibition constant for L-proline.

(

[ ]
[ ]
)

[ ]
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The effect of TtPRODH R288M/R289M on TtP5CDH was carried out similarly to the
assays described above using 100 µM L-P5C as a substrate and varying TtPRODH
R288M/R289M from 1 to 25 µM in the assays.
Test for substrate channeling
Optimization of the TtPRODH:TtP5CDH ratio for channeling assays
Varying concentrations of TtPRODH (0.1 µM to 10 µM) were mixed with 0.5
µM of TtP5CDH in 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl. A separate
substrate solution was prepared by mixing proline (1 mM), CoQ1 (0.1 mM), and NAD+
(0.2 mM) in 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl. Equal volumes of
the substrate and enzyme solutions were then mixed via single-mixing on a SF-61DX2
stopped-flow spectrophotometer. The reaction was monitored at 340 nm with a 1 cm path
length observation cell. A molar extinction coefficient of 6400 cm-1 M-1 [34] was used to
calculate concentration of NADH formed during the coupled assay.
The strategy described by Geck and Kirsch [20] was used for testing substrate
channeling between TtPRODH and TtP5CDH. The experiment uses proline as the
substrate for PRODH and monitors formation of NADH, a product of P5CDH activity.
This coupled reaction (channeling assay) is performed at increasing concentrations of
inactive mutants of TtP5CDH and TtPRODH. The inactive mutants of P5CDH were
TtP5CDH C322A, DrP5CDH C325A, and Put2p C351A. The inactive mutant of
TtPRODH used for these assays was TtPRODH R288M/R289M. The lack of enzymatic
activity in the TtPRODH and TtP5CDH mutants was confirmed by activity assays
described above. Bovine serum albumin (BSA), a protein unrelated to proline
metabolism, was used as negative control in the channeling assays. The final
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concentration of TtPRODH and TtP5CDH used in these assays was 0.5 µM of monomer
each. The final concentrations of catalytically inactive mutants were 0, 1, 2, 3, 5, 12.5,
and 25 µM (monomer). This resulted in 0 – 50 fold inactive mutant to wild-type enzyme
ratio.
For the channeling assays, a mixture of TtPRODH (0.5 µM) and TtP5CDH (0.5
µM) was prepared in 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl. A separate
substrate solution was prepared by mixing proline (1 mM), CoQ1 (0.1 mM), and NAD+
(0.2 mM) in 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl. Equal volumes of
the substrate and enzyme solutions were then mixed via single-mixing on a SF-61DX2
stopped-flow spectrophotometer. The reaction was monitored at 340 nm with 1 cm path
length observation cell. Molar extinction coefficient of 6400 cm-1 M-1 [34] was used to
calculate the concentration of NADH formed during the channeling assay. Reduction of
CoQ1 alone causes a minor spectral decrease at 340 nm due to the absorbance overlap of
CoQ1 at 340 nm. To correct for this interference, the absorbance decrease at 340 nm due
to CoQ1 reduction was subtracted from the channeling assays by recording changes at
340 nm in the absence of NAD+. Linear regression analysis was used for determining the
rate of NADH formation in each assay. The change in NADH formation rates are also
presented as the percent channeling activity relative to assays without inactive mutant.
The non-channeling PRODH-P5CDH reaction was simulated as previously
described [35] using a diffusion-limited two-enzyme model (Equation 2.3, 2.4).

[

]

( )

(

)
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In the above equation, v1 is the experimentally determined rate of PRODH activity under
the specified assay conditions with 1 mM proline, t is time in sec, Km2 (42.5 µM L-P5C)
and v2 (0.26 µM/sec) are the steady-state Michaelis-Menten constants Km and V,
respectively, for TtP5CDH, and τ is the transient time (sec) required to attain steady-state
formation of product (i.e., NADH).
Biotin labeling of TtPRODH
TtPRODH mutants S8C and A88C were purified as described above and labeled
with biotin at the newly incorporated cysteine residue using the thiol-reactive N(Biotinoyl)-N'-(iodoacetyl)ethylenediamine (BIAM) reagent. A 5 mM stock of BIAM
was prepared by dissolving in DMSO. Under anaerobic conditions, purified TtPRODH
mutants S8C and A88C and BIAM were mixed at final concentrations of 51 µM
(TtPRODH) and 715 µM (BIAM). After allowing the labeling reaction to proceed
overnight at 4oC, 25 mM β-mercaptoethanol was added to quench the unreacted BIAM.
Crude biotin-labeled TtPRODH was separated from the quenched BIAM using a PD-10
desalting column. The concentration of total protein was measured using the Pierce 660
nm Protein Assay Reagent (Pierce). Biotin labeling of TtPRODH was confirmed by
Western blot analysis using streptavidin-conjugated Horse Radish Peroxidase (Pierce).
ECLprime reagents (GE Healthcare) were used for detection and visualization of biotinlabeled TtPRODH.
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Protein-protein interaction analysis by SPR
Immobilization of TtPRODH on streptavidin sensor chip
The streptavidin (SA) sensor chip was first washed with HBS-EP buffer (10 mM
HEPES, pH 7.4, 0.15 M NaCl, 3.4 mM EDTA, and 0.05% surfactant P20) for 6 min (20
µl/min flow rate). Prior to immobilization, the SA sensor chip was activated with three
consecutive 40 µl injections of activating buffer (1 M NaCl and 50 mM NaOH).
Biotinylated TtPRODH mutants S8C and A88C were then diluted in HBS-EP to a final
concentration of 250 µM and injected with a flow rate of 5 µl/min onto flow cells 2
(TtPRODH S8C) and 4 (TtPRODH A88C). Sensor chip flow cells 1 and 3 were not
exposed to TtPRODH mutants and were used as reference cells.
Preliminary experiments were carried out to test the interaction of immobilized
TtPRODH S8C and A88C ligands with analytes such as TtP5CDH, DrP5CDH and BSA.
The analytes were equilibrated in HBS-EP buffer and diluted to a concentration of 1 µM
immediately prior to injection. Each protein analyte was then injected onto flow cells 1-4
for 2 min followed by a 5 min dissociation phase at a flow rate of 30 µl/min.
Binding analysis of TtP5CDH
The SA sensor chip with immobilized TtPRODH A88C on flow cell 4 was first
washed with regeneration buffer (2 M NaCl) at a flow rate of 30 µl/min for 3 min
followed by equilibration with HBS-EP buffer (30 µl/min). Wild-type TtP5CDH was
equilibrated with HBS-EP buffer and diluted to different concentrations ranging from 0.5
to 7.5 µM (monomer). From lowest to highest concentration, wild-type TtP5CDH was
injected for 2 min (30 µl/min) followed by a 5 min dissociation phase at a flow rate of 30
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µl/min with HBS-EP buffer. The SA sensor chip was regenerated using 90 µl of 2 M
NaCl (30 µl/min) and equilibrated with HBS-EP buffer (30 µl/min, 5 min) after each
injection of TtP5CDH. The resulting sensorgrams were globally fitted to 1:1 Langmuir
PRODH-P5CDH binding model using BIA-evaluation software 3.1. The experiments
were carried out at 25oC. All buffers were filtered and degassed prior to injection on SA
sensor chip. Signals from the reference flow cells were subtracted from the sensorgrams.

RESULTS
Competitive inhibition of TtP5CDH by proline
The crystal structure of TtP5CDH [19] shows several ligands containing a
carboxylate moiety (COO-) bind at the TtP5CDH active site. L-proline (PDB ID:2J40)
and glutamate (PDB ID:2BHQ) were among these ligands. The carboxyl moiety of
proline is 2.7 Å from the hydroxyl group of active site Ser321 and 3.0 Å from the
backbone amide nitrogen atoms of Gly477 and Ala478 (Figure 3A). Such bond distances
can favor hydrogen bonding or electrostatic interaction and thereby stabilize ligand
binding [36]. The orientation of the carboxyl group of the other ligands is identical to
proline and glutamate. This suggests that the binding of proline to the active site is stable
and not an artifact of TtP5CDH crystallization. Hence, we decided to test the possibility
of proline as an inhibitor of TtP5CDH.
The effect of proline on P5CDH initial velocity was determined and is shown as a
direct plot in Figure 3B and a double reciprocal plot of 1/v versus 1/[S] with varying
proline concentrations in Figure 3C. The steady-state kinetic parameters for TtP5CDH
were estimated as Km of 42.7 µM DL-P5C and kcat of 0.52 s-1 (Table 3). As is
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Figure 3- Competitive inhibition of TtP5CDH by L-Proline. A) Molecular
representation of L-proline bound to TtP5CDH active site (PDB ID:2J40). Ligands Lproline and NAD+ are represented as sticks. Distance between carboxyl moiety of proline
and active site residues are shown using yellow dotted line with distance represented in
Å. TtP5CDH is represented as cartoon (cyan). Figure was generated using PyMol
molecular graphics system [37]. B) Michaelis-Menten plot and C) Double reciprocal plot
of initial velocity TtP5CDH versus L-P5C substrate concentration with proline as
competitive inhibitor with concentrations 0 mM (●); 2 mM (○); 4 mM (▼); 6 mM () ;
8 mM (); 10 mM (); and 15 mM (). Regression analysis was performed by global
fitting of data to Michaelis-Menten equation using Sigmaplot 12 (Systat Software Inc.).
Kinetic parameters from the fitting are kcat = 0.43 ± 0.02 sec-1, Km = 27.7 ± 4.3 µM, and
KI(pro) = 3.9 ± 0.7 mM proline.
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characteristic of competitive inhibition, the apparent V of P5CDH does not change with
inhibitor (proline) concentration. The data fits well with a competitive inhibition model
(equation 2.2) with an inhibition constant (KI) of 3.9 mM proline. In order to eliminate
interference from proline acting as a competitive inhibitor of P5CDH, we chose to test
TtPRODH-TtP5CDH substrate channeling using proline concentrations < 3.9 mM. The
subsequent channeling assays were thus performed with 1 mM proline, which is not only
< KI(pro), but is also below Km(pro) for TtPRODH. The kinetics parameters determined for
TtPRODH are Km of 8.19 ± 0.34 mM proline and 162.2 ± 7.6 µM CoQ1 with overall kcat
of 17.04 ± 0.42 sec-1.
TtPRODH-TtP5CDH coupled reaction and non-channeling two-enzyme modeling

Figure 4 – Effect of TtPRODH enzyme concentration on channeling reaction. NAD+
reduction rate was calculated from slope of progress curves at 340 nm. The reaction
mixture contained 0.5 µM TtP5CDH, 1 mM proline, 0.2 mM NAD+, and 0.1 mM CoQ1.
TtPRODH was varied from 0.1 µM to 10 µM. Assays for each TtPRODH concentration
was carried out in triplicate.
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Before performing TtPRODH-TtP5CDH channeling assays, the ratio of
TtPRODH:TtP5CDH was first optimized. This was done to ensure that the coupled
TtPRODH-TtP5CDH reaction was not limited by the concentration of either enzyme.
Figure 4 shows the dependence of NADH formation on the concentration of TtPRODH.
Keeping TtP5CDH fixed at 0.5 µM, NADH formation plateaus above 1 µM TtPRODH.
Thus, an equimolar mixture of 0.5 µM TtPRODH and 0.5 µM TtP5CDH was considered
to be appropriate for testing substrate channeling.
The rate of NADH formation using an equimolar mixture of TtPRODH-TtP5CDH
(0.5 µM:0.5 µM) was compared to that of a diffusion-limited two-enzyme reaction model
(equation 2.3). Figure 5 shows that an equimolar mixture of TtPRODH-TtP5CDH
exhibits a velocity of 0.0803 µM NADH/sec. Simulating a non-channeling reaction for
the formation of NADH by TtPRODH and TtP5CDH using equation 2.3 generates a rate
of 0.0804 µM/sec. The simulated steady-state rate of NADH formation is identical to the
experimental rate, however, the transient time for TtPRODH-TtP5CDH to attain steadystate formation of NADH is much longer for the simulated non-channeling reaction than
for the experimentally observed reaction.

The predicted transient time for a non-

channeling TtPRODH-TtP5CDH mixture is 164.2 sec, whereas the experimentally
observed transient time is 38.5 sec. The 4-fold decrease in transient time in the
experimental curve relative to the simulated curve is suggestive of substrate channeling
between TtPRODH and TtP5CDH. The shorter time to reach steady-state formation of
NADH may be due to increased local concentration of P5C/GSA at the P5CDH active
site [38].
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Figure 5- Observed NADH formation from TtPRODH-TtP5CDH channeling assay
and simulated non-channeling TtPRODH-TtP5CDH reaction. Solid line represents
NADH formed in a channeling assay by an equimolar mixture of TtPRODH and
TtP5CDH using 1 mM proline as substrate. Dotted line represents simulated NADH
formation by a non-channeling two-enzyme model (equation 2.3) using experimentally
determined values of v1 (0.08 µM/sec), Km2 (42.7 µM), and v2 (0.26 µM/sec).
An explanation for decreased lag time to NADH formation could be allosteric
activation by one of the two enzymes [39]. In a proline:DCPIP oxidoreductase assay with
1 mM proline, 0.5 µM TtPRODH alone reduces 24.9 µM DCPIP/min whereas addition of
50-fold excess of inactive TtP5CDH C322A or Put2p C351A changes the rate to 19.26
and 23.11 µM DCPIP reduced/min, respectively. TtP5CDH was also tested for allosteric
effects by TtPRODH. With 100 µM L-P5C present as P5CDH substrate, 50-fold excess
of TtPRODH R288M/R289M caused a slight decrease in TtP5CDH activity from 14.6
µM NADH formed/min to 11 µM NADH/min. Both TtPRODH and TtP5CDH exhibit a
negligible inhibitory effect on each other but no evidence of allosteric activation was
observed.
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Effect of inactive mutants on TtPRODH-TtP5CDH channeling assays
To further test the channeling hypothesis, inactive mutants of TtP5CDH and
TtPRODH were used as competitors of the putative TtPRODH-TtP5CDH channeling
complex. Inactive TtPRODH (TtPRODH mutant R288M/R289M) was created by
replacing two catalytic arginine residues (Arg288 and Arg289) which are responsible for
ionic interactions with the carboxylate moiety of proline thereby stabilizing proline
binding [40]. The inactive variant of TtP5CDH (TtP5CDH C322A) was generated by
mutating Cys322 which is the active site nucleophile that attacks the aldehyde carbon of
GSA and forms an essential thiohemiacetal tetrahedral intermediate. Active site
mutations did not significantly alter the oligomeric structures of TtPRODH and
TtP5CDH as observed by size-exclusion chromatography and small-angle X-ray
scattering (personal communications Dr. John Tanner’s group, University of MissouriColumbia).
Figure 6 shows that the addition of the TtP5CDH inactive mutant (TtP5CDH
C322A) to a mixture of TtPRODH-TtP5CDH caused a severe decrease in the rate of
NADH formation (Figure 6A). In the absence of TtP5CDH C322A, the velocity of
NADH formation by the TtPRODH-TtP5CDH mixture was 0.1 µM NADH/sec whereas
in the presence of 50-fold excess of TtP5CDH C322A (25 µM) the rate decreased 5-fold
to 0.02 µM NADH/sec. This is about an 80% decrease in the rate of product formation
(Figure 6B). The rate of decrease in NADH formation has a linear correlation with the
amount of TtP5CDH C322A added to the reaction. From an extrapolation on the x-axis, it
is predicted that 63-fold excess of TtP5CDH C322A would lead to complete inhibition of
the channeling reaction. The amount of inactive mutant added to the reaction was limited
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Figure 6- Test for substrate channeling. A) Time course of NADH formation at 340
nm with varying concentrations of TtP5CDH C322A. The concentration of inactive
mutant was varied from 0 to 25 µM. Grey bar corresponds to increasing TtP5CDH
C322A concentration. NADH formation decreases with increasing TtP5CDH C322A
concentration. The reaction mixture contained 0.5 µM TtP5CDH, 0.5 µM TtPRODH, 1
mM proline, 0.2 mM NAD+, 0.1 mM CoQ1 and increasing concentrations of TtP5CDH
C322A. Percent channeling rate is calculated from slope of progress curve. B) Percent
channeling rates are plotted for the different inactive P5CDH and TtPRODH mutants.
Shown in the plot are- TtP5CDH C322A (), TtPRODH R288M/R289M (●), DrP5CDH
C325A (), Put2p C351A (○), and BSA (). A linear fit for the effect of each mutant on
the NADH formation rate is shown.
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to 50-fold excess due to experimental constraints such as volume of protein added,
concentration of glycerol and buffering agents required for protein solubility. Addition of
buffer components alone did not have any effect on the rate of NADH formation. The
effect of adding the TtPRODH inactive mutant (TtPRODH R288M/R289M) to the
channeling reaction was similar to TtP5CDH inactive mutant albeit to a lesser extent. At
a 50-fold excess of TtPRODH R288M/R289M (25 µM) relative to wild-type TtPRODH,
a 2-fold decrease in the rate of NADH formation was observed from 0.1 µM/sec to 0.054
µM/sec.
To test the effects of inactive P5CDH from another organism, inactive mutants of
P5CDH from D. radiodurans (DrP5CDH C325A) and S. cerevisiae (Put2p C351A) were
added to the TtPRODH:TtP5CDH reaction mixture. In contrast to inactive TtP5CDH,
DrP5CDH and Put2p inactive mutants had no significant effect on NADH formation rates
as shown in Figure 6B. In addition, BSA showed no effect on the TtPRODH:TtP5CDH
reaction mixture. Interestingly, a slight increase in NADH formation was observed with
BSA. The slight increase in activity may be attributed to a general stabilizing effect of
BSA on enzymatic activity [41-44]. Although the mechanism is not fully understood, it
has been proposed that BSA increases protein stability and decreases interaction of
enzymes with the reaction vessel and air-solvent interface by acting as a surfactant [42].
In summary, the results shown in Figure 6 show that only TtP5CDH C322A and
TtPRODH R288M/R289M cause a decrease in NADH formation rate.
Because the highest concentration of inactive mutant in the test for channeling
assays is 25 µM and, approximately 20 µM P5C is generated during a 200 sec assay, one
possible explanation for the decrease in NADH formation caused by TtP5CDH C322A is
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the binding of P5C/GSA by the inactive mutant. Binding of P5C/GSA by an inactive
P5CDH mutant could possibly decrease the amount of P5C/GSA available for catalysis,
thereby causing a decrease in the overall formation of NADH. The dissociation constant
(KD) is the best estimate of substrate binding affinity, however, it is difficult to estimate a
KD value for the binding of P5C/GSA to TtP5CDH because P5C/GSA are in a pHdependent equilibrium in aqueous solution [9]. For this reason, Km values were used as a
determinant of substrate binding affinity. Table 3 reports the steady-state kinetic
parameters that were determined for TtP5CDH, Put2p, and DrP5CDH. The Km value for
TtP5CDH is 42.7 µM and for Put2p, the Km is 2-fold higher at 104 µM. The Km value for
DrP5CDH (Km = 282.3 µM) is nearly 7-fold higher than TtP5CDH. If the inactive mutant
of TtP5CDH decreases channeling simply by binding P5C/GSA, then Put2p would also
be expected to have an effect on the channeling assay, albeit to a lesser extent (~ 2-fold
less).
Table 3 – Steady-state kinetic parameters of monofunctional P5CDH
from various species

Km (µM L-P5C)

kcat (sec-1)

kcat/Km (M-1sec-1)

TtP5CDH

42.7 1.1

0.52 0.03

1.22x104

DrP5CDH

282.3 6.4

1.6 0.1

5.67x103

Put2p

104.2 4.4

1.49 0.26

1.43x104

The results shown in Figure 6, however, show that Put2p has no effect on NADH
formation indicating that the effects of the inactive TtP5CDH mutant on the TtPRODHTtP5CDH reaction are not caused by sequestration of P5C/GSA. Furthermore, the
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inactive TtPRODH mutant, which does not bind P5C/GSA, also inhibited the TtPRODHTtP5CDH reaction consistent with the inactive TtPRODH and TtP5CDH mutants
lowering NADH formation by disrupting a TtPRODH:TtP5CDH complex.
Analysis of PRODH-P5CDH interactions by SPR
In order to further investigate TtPRODH-TtP5CDH substrate channeling, binding
interactions between TtPRODH and TtP5CDH were investigated by SPR. In the SPR
analysis, TtPRODH was used as the immobilized ligand and TtP5CDH was the analyte.
The following strategy was used for biotinylating TtPRODH and immobilizing it on a
BIAcore streptavidin (SA) sensor chip.
TtPRODH does not have any cysteine residues. This allowed us to specifically
introduce cysteine residues on the outer surface of TtPRODH via site-directed
mutagenesis. After careful analysis of the surface residues, Ser8 located near the Nterminus and Ala88 located near the top of the PRODH β8α8 barrel were chosen for
mutagenesis. These residues were strategically chosen for replacing with cysteine so that
biotinylated TtPRODH could be immobilized on the SA chip in two different
orientations. Figure 9 shows the predicted orientation of TtPRODH mutants S8C and
Ala88C after immobilization on the SA chip. TtPRODH S8C should be immobilized
near the N-terminus leaving the side and top of the PRODH β8α8 barrel exposed to
solvent (Figure 9). Conversely, TtPRODH A88C is predicted to be immobilized near the
top of the PRODH β8α8 barrel with the N-terminus region exposed to solvent. These
contrasting immobilized configurations allowed us to probe two different regions of
TtPRODH for binding to TtP5CDH.
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Purified TtPRODH mutants S8C and A88C required the presence of the reducing
agent Tris(3-hydroxypropyl)phosphine (THP) to prevent precipitation during purification.
The specific activities of TtPRODH mutants S8C and A88C were 25.4 U/mg and 19.8
U/mg, respectively, which are somewhat lower than wild-type TtPRODH (34 U/mg). The
engineered surface cysteine residues on TtPRODH were biotinylated using the thiolreactive BIAM reagent and the incorporation of the biotin label was verified by Western
analysis as shown in Figure 7. There was some loss of enzymatic activity during the
labeling procedure. The specific activities for biotin-labeled TtPRODH mutants S8C and
A88C were 15.4 U/mg and 14.6 U/mg, respectively.

Coomassie
Staining

Western blot
Streptavidin

Reducing SDS-PAGE
Figure 7 – Labeling of TtPRODH with Biotin. TtPRODH S8C and A88C were labeled
using thiol-reactive biotinylated iodoacetamide (BIAM). Western blotting (bottom panel)
using streptavidin-HRP confirms biotin labeling of TtPRODH A88C and S8C. PD-10
desalting column was used for removing excess BIAM.
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Injection of TtPRODH mutants S8C and A88C elicited a response of 1900 RU
and 2600 RU, respectively, upon being immobilized on the SA chip. Thus, similar
amounts of both proteins were immobilized on the SA chip. After washing the
immobilized surfaces, TtP5CDH (1 µM) was injected onto both surfaces. Figure 8A
shows that a binding response was observed with immobilized TtPRODH A88C but not
with immobilized TtPRODH S8C. This result suggests that TtP5CDH distinguishes
between the two orientations of TtPRODH and specifically recognizes the configuration
of immobilized TtPRODH A88C. It also indicates that the immobilized orientation of
TtPRODH S8C conceals a surface on TtPRODH that is critical for TtP5CDH binding.
Other analytes were also tested for binding to TtPRODH to rule out non-specific
interactions. BSA and DrP5CDH did not show any binding response with either
TtPRODH orientation. This further indicates that the sensorgram response observed with
immobilized TtPRODH A88C is specific for TtP5CDH.
We then proceeded to measure the binding kinetics of TtP5CDH with
immobilized TtPRODH A88C. Increasing concentrations of TtP5CDH were injected onto
the TtPRODH A88C surface. Figure 8B shows that TtP5CDH binds to TtPRODH A88C
in a concentration dependent manner. Global fitting analysis yielded a dissociation
constant (KD) of 3.03 µM and an association constant (KA) of 3.3 x 105 M-1. The
corresponding kon rate constant for binding was 1.49x103 M-1s-1 and koff rate constant was
4.51x10-3 s-1.
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Figure 8A– TtP5CDH binds only to TtPRODH immobilized via A88C. SPR
sensorgram showing binding response after injection of TtP5CDH (1 µM) to immobilized
TtPRODH S8C and A88C with a flow rate of 30 µl/min (HEPES-EP buffer, pH 7.4). The
association and dissociation phases were 300 sec each. The sensorgrams show that a
response is only generated by injection of TtP5CDH onto immobilized TtPRODH A88C.
Signals from the control flow cells have been subtracted from the sensorgrams.
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Figure 8B- SPR binding analysis of TtP5CDH and immobilized TtPRODH A88C.
The concentrations of TtP5CDH injected onto the surface are 0.5 µM (black), 1 µM
(red), 2 µM (green), 3 µM (yellow), 5 µM (blue), and 7.5 µM (pink). The association
phase is the injection of TtP5CDH (0.5-7.5 µM) at 30 µl/min for 120 sec and the
dissociation phase is the flow of HEPES-EP buffer at 30 µl/min for 300 sec. The
overlapping black lines are generated from a global fit of the data to a 1:1 Langmuir
binding isotherm using BIAevaluation 3.0 software. A dissociation constant, KD, of 3.03
µM was determined for TtPRODH and TtP5CDH interaction. Bottom panel shows the
plot of the residuals. The chi square value for the fit was 0.579. Signals from the control
flow cells have been subtracted from the sensorgrams.
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DISCUSSION
There is a growing body of evidence that suggests metabolic processes are more
than just dispersed reactions occurring inside a fluidic container that is, the cell [16, 29,
45]. There appears to be mechanisms by which several intermediates of metabolism are
transferred between sequential enzymes while restricting their diffusion in the cytoplasm
or other cellular compartments [45]. The interactions between enzymes that lead to such
channeling of intermediates range from strong interactions to weak transient interactions
with binding affinities (KD) spanning the nM to µM range [46]. In order to identify the
cellular processes that limit diffusion of metabolites, there is a need to investigate
substrate channeling at the molecular enzyme level. In the case of proline metabolism,
Surber and Maloy first observed that PutA from Salmonella typhimurium catalyzed the
oxidation proline to glutamate by an apparent leaky channel [47]. A more recent study
from our group in conjunction with Dr. John Tanner’s lab (Missouri, Columbia)
confirmed this original proposal by reporting structural and kinetic evidence of an
internal cavity in PutA from B. japonicum for transfer of P5C/GSA from the active site of
PRODH to P5CDH.
The experiments discussed in this chapter were designed to explore the possibility
of substrate channeling in monofunctional PRODH and P5CDH enzymes. Rate
measurements for the coupled TtPRODH-TtP5CDH enzyme pair demonstrates that
steady-state formation of NADH is achieved faster than the theoretical approach to
steady-state by two individual enzymes. Although such rapid product formation can be
explained by allosteric activation by one enzyme on the other [39], our results show that
this is not the case for TtPRODH and TtP5CDH.
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The results from experiments using a catalytically inactive TtP5CDH mutant and
to a lesser extent the inactive TtPRODH mutant, suggests the presence of a dynamic
TtPRODH-TtP5CDH interaction. In aqueous buffer, the functional enzyme pair can be
disrupted by an equally compatible inactive variant of either of TtPRODH or TtP5CDH.
Being structurally identical to wild-type enzymes, the inactive variants most likely form
an identical complex as the wild-type enzyme but one which cannot catalyze coupled
proline oxidation.
Although suggestive of a binding event between TtPRODH and TtP5CDH, the
kinetic experiments do not directly provide any information on enzyme interactions. SPR
was thus used to test for potential physical interactions between TtPRODH and
TtP5CDH. Unexpectedly, the two orientations of TtPRODH immobilized on the SA chip
revealed specific binding interactions between TtPRODH and TtP5CDH. In addition,
DrP5CDH showed no evidence of binding to TtPRODH. Thus, the binding interactions
observed by SPR between TtP5CDH and immobilized TtPRODH A88C appear to be
specific. The KD value estimated for the TtPRODH-TtP5CDH complex is ~ 3 µM which
can be categorized as a weak transient protein-protein interaction [48].
Based on the evidence presented here and the structural data available for
TtPRODH and TtP5CDH, a possible model for how TtPRODH and TtP5CDH physically
interact was explored. Figure 9 shows a representation of the TtPRODH electrostatic
surface. The structure of the hexameric form of TtP5CDH is shown in Figure 10. The
hexamer of TtP5CDH has a hollow core along its longitudinal axis of symmetry. This
hollow cylindrical core, which is approximately 12 Å in diameter and 91 Å in length,
provides exclusive access to all of the six active sites in the hexamer. Apart from the two
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Figure 9 –Molecular and surface representation of TtPRODH. A) TtPRODH is
shown as cartoon representation and colored as rainbow with N-terminus as blue and Cterminus as red (left.) Side chains of residues Ser 8 (Blue) and Ala 88 (Cyan) are
displayed as spheres. B) Coulombic surface representation of TtPRODH oriented as
figure A. C) View turned 180o about the vertical axis. Ser 8 is in a region with basic
residues whereas Ala 88 is located in a region with acidic side chains. These two residues
were chosen since they are in two separate regions of TtPRODH with the most noticeable
surface electrostatics. The coulombic representation used blue color for electropositive
charge and red color for electronegative charge. Either of these two regions can serve as a
possible interface with TtP5CDH. Figures were created using monomeric TtPRODH
structure (PDB ID:2G37) and UCSF Chimera [49].
ends of the hexamer, there are no other major paths into the core. Access to the P5CDH
active site is not possible from outside the hexmeric core. TtP5CDH shares considerable
sequence similarity (similarity 51%, Iidentity 37%) and structural homology with the
P5CDH domain of B. japonicum PutA If we use the P5CDH active site orientation from
the BjPutA structure (PDB ID:3HAZ), we will notice that the substrate P5C/GSA must
enter the core region of TtP5CDH to reach the active site Cys322 and the NAD+ cofactor.
Once GSA is oxidized to glutamate, it appears that glutamate can exit the active site on
the exterior side of the hexamer. It is possible then, that the inner core of the hexamer
facilitates capture of P5C/GSA, thus generating a conduit for channeling P5C/GSA.
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Figure 10 –Molecular and surface representation of TtP5CDH. A) Each chain of
TtP5CDH hexamer is represented as cartoon and with different color. B) Coulombic
surface representation of TtP5CDH oriented as left figure A and C) turned 90o about the
horizontal axis. The Right figure is looking down the inner core of TtP5CDH through
which all the six active site gain access to substrate glutamate semialdehyde. The
coulombic representation used blue color for electropositive charge and red color for
electronegative charge. Figures were created using hexameric structure of TtP5CDH
(PDB ID:2J40) and UCSF Chimera [49].

Based on the considerations above, a docking model of TtPRODH and TtP5CDH
was made using ClusPro [50]. The docking parameters were based on electrostatic
interactions without any constraints on TtPRODH or TtP5CDH orientation. The model
predicts favorable docking interactions between the regions of complementary charged
surfaces of TtPRODH and TtP5CDH. The electropositive N-terminal region of
TtPRODH (blue surface, Figure 9B) appears to dock in close proximity to an
electronegative region (red surface, Figure 10C) of TtP5CDH. Interestingly, the proposed
docking model (Figure 11) is consistent with our results from SPR showing TtP5CDH
only binds to immobilized TtPRODH A88C. The orientation of TtPRODH A88C would
allow for the interactions in the docking model whereas the orientation of TtPRODH S8C
would block the predicted docking interactions. Further analysis is required to
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P5C
Glu

Glu

Glu

Glu

‘
Hexameric TtP5CDH

P5C

Figure 11- A scheme for substrate channeling overlaid on the predicted docking
model of TtPRODH-TtP5CDH - TtPRODH and TtP5CDH are shown as transparent
surfaces with coulombic charge. The orientation of TtP5CDH is identical to that shown in
Figure 10 B. TtPRODH is shown docked on top of TtP5CDH as predicted by ClusPro
[50]. NAD+ and active residues for each of the six active sites of TtP5CDH are shown as
colored sticks. The proposed channeling steps are indicated by grey arrows. The docking
model suggests that after P5C/GSA exits TtPRODH, P5C/GSA is directed toward the
inner core of the TtP5CDH hexamer. Hexameric assembly of TtP5CDH could facilitate
the channeling process by sequestering P5C near the six TtP5CDH active sites. The
surface representation was created using UCSF Chimera [49].
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understand the stoichiometry of a putative TtPRODH-TtP5CDH complex considering
that the TtP5CDH hexamer has a 3-fold symmetry. In addition, a residue conservation
map of the TtP5CDH surface shows a high degree of variability in residues in the region
where TtPRODH-TtP5CDH binding is predicted. This could explain why only TtP5CDH
binds TtPRODH whereas the closely related DrP5CDH does not (sequence similarity
69%, identity 51%).
According to a trend observed by Nooren and Thornton, a transient heterodimer
with a dissociation constant of ~ 3 µM can be expected to have an interface contact area
of approximately 500 Å2 [48]. In order to calculate the interface area between TtPRODH
and TtP5CDH, a more thorough docking analysis is required that takes into account the
solvent water molecules which may affect the TtPRODH-TtP5CDH interface. Overall,
our results provide evidence that the two-step oxidation of proline to glutamate catalyzed
by PRODH and P5CDH from Thermus thermophilus involves a channeling mechanism.
This study lays the groundwork for testing substrate channeling in other monofunctional
PRODH and P5CDH such as the human enzymes. TtPRODH and TtP5CDH will also
serve as a model for investigating substrate channeling between other individual enzymes
that catalyze consecutive reactions.

67
REFERENCES
1.
2.

3.

4.

5.

6.
7.
8.
9.

10.

11.
12.

13.

14.

Phang, J.M., J. Pandhare, and Y. Liu, The metabolism of proline as
microenvironmental stress substrate. J Nutr, 2008. 138(10): p. 2008S-2015S.
Takagi, H., Proline as a stress protectant in yeast: physiological functions,
metabolic regulations, and biotechnological applications. Appl Microbiol
Biotechnol, 2008. 81(2): p. 211-23.
Krishnan, N., et al., Characterization of a Helicobacter hepaticus putA mutant
strain in host colonization and oxidative stress. Infect Immun, 2008. 76(7): p.
3037-44.
Curtis, J., G. Shearer, and D.H. Kohl, Bacteriod proline catabolism affects N2
fixation rate of drought-stressed soybeans. Plant Physiol., 2004. 136: p. 33133318.
Kohl, D.H., et al., Proline metabolism in N2-fixing root nodules: Energy transfer
and regulation of purine synthesis. Proc. Natl. Acad. Sci. USA, 1988. 85: p. 20362040.
Lamour, N., et al., Proline metabolism in procyclic Trypanosoma brucei is downregulated in the presence of glucose. J. Biol. Chem., 2005. 280(12): p. 11902-10.
Tanner, J.J., Structural biology of proline catabolism. Amino Acids, 2008. 35(4):
p. 719-30.
Arentson, B.W., N. Sanyal, and D.F. Becker, Substrate channeling in proline
metabolism. Front Biosci, 2012. 17: p. 375-88.
Bearne, S.L. and R. Wolfenden, Glutamate gamma-semialdehyde as a natural
transition state analogue inhibitor of Escherichia coli glucosamine-6-phosphate
synthase. Biochemistry, 1995. 34(36): p. 11515-20.
Bearne, S.L., O. Hekmat, and J.E. Macdonnell, Inhibition of Escherichia coli CTP
synthase by glutamate gamma-semialdehyde and the role of the allosteric effector
GTP in glutamine hydrolysis. Biochem J, 2001. 356(Pt 1): p. 223-32.
Thoden, J.B., et al., The small subunit of carbamoyl phosphate synthetase:
snapshots along the reaction pathway. Biochemistry, 1999. 38(49): p. 16158-66.
Farrant, R.D., et al., Pyridoxal phosphate de-activation by pyrroline-5-carboxylic
acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type
II. J Biol Chem, 2001. 276(18): p. 15107-16.
Nomura, M. and H. Takagi, Role of the yeast acetyltransferase Mpr1 in oxidative
stress: regulation of oxygen reactive species caused by a toxic proline catabolism
intermediate. Proc Natl Acad Sci U S A, 2004. 101(34): p. 12616-21.
Maxwell, S.A. and G.E. Davis, Differential gene expression in p53-mediated
apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci U
S A, 2000. 97(24): p. 13009-14.

68
15.

16.
17.

18.

19.
20.

21.

22.

23.

24.

25.

26.

27.
28.

Srivastava, D., et al., Crystal structure of the bifunctional proline utilization A
flavoenzyme from Bradyrhizobium japonicum. Proceedings of the National
Academy of Sciences, 2010. 107(7): p. 2878-2883.
Ovadi, J., Physiological significance of metabolic channelling. J Theor Biol,
1991. 152(1): p. 1-22.
Singh, R.K., et al., Small-angle X-ray scattering studies of the oligomeric state
and quaternary structure of the trifunctional proline utilization A (PutA)
flavoprotein from Escherichia coli. J Biol Chem, 2011. 286(50): p. 43144-53.
White, T.A., et al., Structure and kinetics of monofunctional proline
dehydrogenase from Thermus thermophilus. J Biol Chem, 2007. 282(19): p.
14316-27.
Inagaki, E., et al., Crystal structure of Thermus thermophilus Delta1-pyrroline-5carboxylate dehydrogenase. J Mol Biol, 2006. 362(3): p. 490-501.
Geck, M.K. and J.F. Kirsch, A novel, definitive test for substrate channeling
illustrated with the aspartate aminotransferase/malate dehydrogenase system.
Biochemistry, 1999. 38(25): p. 8032-7.
Rakus, D., et al., Interaction between muscle aldolase and muscle fructose 1,6bisphosphatase results in the substrate channeling. Biochemistry, 2004. 43(47):
p. 14948-57.
James, C.L. and R.E. Viola, Production and characterization of bifunctional
enzymes. Substrate channeling in the aspartate pathway. Biochemistry, 2002.
41(11): p. 3726-31.
Lherbet, C., et al., Absence of substrate channeling between active sites in the
Agrobacterium tumefaciens IspDF and IspE enzymes of the methyl erythritol
phosphate pathway. Biochemistry, 2006. 45(11): p. 3548-53.
Szabo, A., L. Stolz, and R. Granzow, Surface plasmon resonance and its use in
biomolecular interaction analysis (BIA). Curr Opin Struct Biol, 1995. 5(5): p.
699-705.
Dunn, M.F., et al., The tryptophan synthase bienzyme complex transfers indole
between the alpha- and beta-sites via a 25-30 A long tunnel. Biochemistry, 1990.
29(37): p. 8598-607.
Zhang, S., et al., Chorismate mutase-prephenate dehydratase from Escherichia
coli. Study of catalytic and regulatory domains using genetically engineered
proteins. J Biol Chem, 1998. 273(11): p. 6248-53.
Thoden, J.B., et al., Structure of carbamoyl phosphate synthetase: a journey of 96
A from substrate to product. Biochemistry, 1997. 36(21): p. 6305-16.
Lu, Y., Y.H. Zhang, and L.R. Lynd, Enzyme-microbe synergy during cellulose
hydrolysis by Clostridium thermocellum. Proc Natl Acad Sci U S A, 2006.
103(44): p. 16165-9.

69
29.
30.
31.
32.
33.

34.
35.

36.
37.
38.

39.

40.

41.

42.
43.

44.

Srere, P.A. and J. Ovadi, Enzyme-enzyme interactions and their metabolic role.
FEBS Lett, 1990. 268(2): p. 360-4.
Williams, I. and L. Frank, Improved chemical synthesis and enzymatic assay of
delta-1-pyrroline-5-carboxylic acid. Anal Biochem, 1975. 64(1): p. 85-97.
Grauschopf, U., A. Fritz, and R. Glockshuber, Mechanism of the electron transfer
catalyst DsbB from Escherichia coli. Embo J, 2003. 22(14): p. 3503-13.
Lineweaver, H. and D. Burk, The determination of enzyme dissociation constants.
J. Am. Chem. Soc., 1934. 56: p. 658-666.
Becker, D.F. and E.A. Thomas, Redox properties of the PutA protein from
Escherichia coli and the influence of the flavin redox state on PutA-DNA
interactions. Biochemistry, 2001. 40: p. 4714-4722.
Srivastava, D., et al., The three-dimensional structural basis of type II
hyperprolinemia. J Mol Biol, 2012. 420(3): p. 176-89.
Meek, T.D., E.P. Garvey, and D.V. Santi, Purification and characterization of the
bifunctional thymidylate synthetase-dihydrofolate reductase from methotrexateresistant Leishmania tropica. Biochemistry, 1985. 24(3): p. 678-86.
Xu, D., C.J. Tsai, and R. Nussinov, Hydrogen bonds and salt bridges across
protein-protein interfaces. Protein Eng, 1997. 10(9): p. 999-1012.
DeLano, W.L., The PyMOL Molecular Graphics System. DeLano Scientific, San
Carlos, CA, USA., 2002.
Szabados, E. and R.I. Christopherson, Relationship between the catalytic sites of
human bifunctional IMP synthase. The International Journal of Biochemistry &
Cell Biology, 1998. 30(8): p. 933-942.
Baker, P., J. Carere, and S.Y. Seah, Substrate specificity, substrate channeling,
and allostery in BphJ: an acylating aldehyde dehydrogenase associated with the
pyruvate aldolase BphI. Biochemistry, 2012. 51(22): p. 4558-67.
Zhang, M., et al., Structures of the Escherichia coli PutA proline dehydrogenase
domain in complex with competitive inhibitors. Biochemistry, 2004. 43(39): p.
12539-48.
Gonzalez, N., J. Wiggs, and M.J. Chamberlin, A simple procedure for resolution
of Escherichia coli RNA polymerase holoenzyme from core polymerase. Arch
Biochem Biophys, 1977. 182(2): p. 404-8.
Ray Williams, M.K.a.R.S., BSA and Restriction Enzyme Digestions Promega
Notes, 1996. 59.
Manevski, N., et al., Albumin stimulates the activity of the human UDPglucuronosyltransferases 1A7, 1A8, 1A10, 2A1 and 2B15, but the effects are
enzyme and substrate dependent. PLoS One, 2013. 8(1): p. e54767.
Yang, B. and C.E. Wyman, BSA treatment to enhance enzymatic hydrolysis of
cellulose in lignin containing substrates. Biotechnol Bioeng, 2006. 94(4): p. 6117.

70
45.

46.
47.

48.

49.
50.
51.

52.
53.

54.
55.

56.

57.

58.

Huang, X., H.M. Holden, and F.M. Raushel, Channeling of substrates and
intermediates in enzyme-catalyzed reactions. Annu Rev Biochem, 2001. 70: p.
149-80.
Perkins, J.R., et al., Transient protein-protein interactions: structural, functional,
and network properties. Structure, 2010. 18(10): p. 1233-43.
Surber, M.W. and S. Maloy, The PutA protein of Salmonella typhimurium
catalyzes the two steps of proline degradation via a leaky channel. Arch Biochem
Biophys, 1998. 354(2): p. 281-7.
Nooren, I.M. and J.M. Thornton, Structural characterisation and functional
significance of transient protein-protein interactions. J Mol Biol, 2003. 325(5): p.
991-1018.
Pettersen, E.F., et al., UCSF Chimera--a visualization system for exploratory
research and analysis. J Comput Chem, 2004. 25(13): p. 1605-12.
Comeau, S.R., et al., ClusPro: an automated docking and discrimination method
for the prediction of protein complexes. Bioinformatics, 2004. 20(1): p. 45-50.
Chen, M., et al., Directed evolution of an artificial bifunctional enzyme, gammaglutamyl kinase/gamma-glutamyl phosphate reductase, for improved osmotic
tolerance of Escherichia coli transformants. FEMS Microbiol Lett, 2006. 263(1):
p. 41-7.
Bennett, B.D., et al., Absolute metabolite concentrations and implied enzyme
active site occupancy in Escherichia coli. Nat Chem Biol, 2009. 5(8): p. 593-9.
Csonka, L.N., Regulation of cytoplasmic proline levels in Salmonella
typhimurium: effect of osmotic stress on synthesis, degradation, and cellular
retention of proline. J Bacteriol, 1988. 170(5): p. 2374-8.
Roesser, M. and V. Muller, Osmoadaptation in bacteria and archaea: common
principles and differences. Environ Microbiol, 2001. 3(12): p. 743-54.
Whatmore, A.M., J.A. Chudek, and R.H. Reed, The effects of osmotic upshock on
the intracellular solute pools of Bacillus subtilis. J Gen Microbiol, 1990. 136(12):
p. 2527-35.
Kosuge, T. and T. Hoshino, Construction of a proline-producing mutant of the
extremely thermophilic eubacterium Thermus thermophilus HB27. Appl Environ
Microbiol, 1998. 64(11): p. 4328-32.
Chen, C., et al., Tomato QM-like protein protects Saccharomyces cerevisiae cells
against oxidative stress by regulating intracellular proline levels. Appl Environ
Microbiol, 2006. 72(6): p. 4001-6.
Morita, Y., S. Nakamori, and H. Takagi, L-proline accumulation and freeze
tolerance of Saccharomyces cerevisiae are caused by a mutation in the PRO1
gene encoding gamma-glutamyl kinase. Appl Environ Microbiol, 2003. 69(1): p.
212-9.

71
59.

Jaksic, T., D.A. Wagner, and V.R. Young, Plasma proline kinetics and
concentrations in young men in response to dietary proline deprivation. Am J
Clin Nutr, 1990. 52(2): p. 307-12

72

CHAPTER 3
Purification and Characterization
of Put1p and Put2p from
Saccharomyces cerevisiae
Note: This chapter contains results published in the research article: “Purification and
characterization of Put1p from Saccharomyces cerevisiae.” Wanduragala S*, Sanyal N*,
Liang X, Becker DF. Arch Biochem Biophys. 2010 Jun 15;498(2):136-42. (*Equal
contribution). Permission for usage in thesis obtained from Elsevier B.V.
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INTRODUCTION
The oxidative conversion of proline to glutamate involves two enzymes, a flavin
dependent proline dehydrogenase (PRODH) and a NAD+-dependent ∆1-pyrroline-5carboxylate (P5C) dehydrogenase (P5CDH). PRODH and P5CDH help organisms
respond to changes in the nutritional environment by initiating the breakdown of proline
as a source for nitrogen, carbon, and energy [1-6]. In Saccharomyces cerevisiae, Put1p
and Put2p are the corresponding PRODH and P5CDH enzymes, respectively (Scheme 1)
[7]. In yeast and other eukaryotes, PRODH and P5CDH are localized in the mitochondria
[8, 9]. PRODH catalyzes the first step of proline oxidation by generating P5C, an
intermediate in the proline catabolic pathway (see Scheme 1). The reaction involves two
phases or two half-reactions. In the reductive half-reaction electrons are transferred from
proline to the flavin adenine dinucleotide cofactor to form P5C. The second phase (i.e.,
oxidative half-reaction) of the catalytic cycle involves oxidation of reduced flavin
(FADH2) to regenerate FAD. P5C is then hydrolyzed to γ-glutamic acid semialdehyde
(GSA) which is subsequently oxidized by P5CDH to form glutamate and NADH.

Scheme 1- Overview of proline catabolism in S. cerevisiae.
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Expression of the PUT1 and PUT2 genes in yeast is sensitive to proline levels and
nitrogen quality. In the presence of preferred nitrogen sources such as glutamine and
ammonia, PUT gene expression is repressed [10]. In nitrogen limiting environments,
PUT1 and PUT2 expression is upregulated coinciding with derepression of the PUT4
gene which encodes a proline specific transporter [10]. Activation of the PUT1 and PUT2
genes is regulated by Put3p, a transcriptional regulator which directly senses proline and
belongs to the Zn(II)2Cys6 protein family [11-13]. Binding of proline to Put3p leads to a
20-fold activation of the PUT genes [12]. Put3p also induces small increases in PUT gene
expression independently of proline in response to poor nitrogen sources [13]. The
resulting Put3p activation of the PUT1 and PUT2 genes enables yeast to utilize proline as
a nitrogen source in coordination with glutamate dehydrogenase (Gdh2p) which
oxidatively deaminates glutamate to generate ammonia and α-ketoglutarate (Scheme 1)
[10, 14].
Human PRODH (PRODH1), also known as proline oxidase (POX1), is of particular
importance as it has been shown to have unique roles in regulating cell survival and
apoptotic pathways [1, 15]. Expression of human PRODH is upregulated by the tumor
suppressor p53 protein with increased PRODH activity leading to induction of cell death
pathways and helping to prevent cancer progression [16, 17]. Using a mouse xenograft
tumor model, Phang and colleagues recently showed that PRODH activity significantly
reduces tumor formation [18]. The mechanism by which human PRODH contributes to
apoptosis involves the generation of reactive oxygen species such as superoxide anions
either directly at the enzyme active site or indirectly due to increased electron flux in the
mitochondrial electron pathway.
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Although PRODH has important roles in energy metabolism, nitrogen utilization, and
in mammals, the programmed cell death pathway, detailed information about the
biochemical and structural properties of PRODH from a eukaryotic organism are still
lacking. In bacteria, the best characterized PRODH enzymes from bacteria are the
bifunctional PutA enzymes which encode PRODH and P5CDH on a single polypeptide
and the monofunctional PRODH enzyme from Thermus thermophilus (TtPRODH) [19,
20]. X-ray crystal structures of the PRODH domain of PutA from Escherichia coli
(EcPutA) and TtPRODH show a common (βα)8 barrel fold with a noncovalently bound
FAD cofactor [19-21]. Human PRODH and Put1p most likely share the same (βα)8
barrel fold and sequence alignments with the bacterial enzymes show human PRODH
and Put1p also share important residues for substrate and FAD binding [19].
To better understand PRODH and P5CDH enzymes from eukaryotic organisms, we
sought to purify and characterize Put1p and Put2p from S. cerevisiae. Particular focus
was given to the oxidative half-reaction of Put1p and its reactivity with molecular oxygen
as it may provide insight into the physiological role of human PRODH in superoxide
production and apoptotic signaling pathways. The direct electron acceptor for Put1p in
the oxidative half-reaction has not been demonstrated but a functional mitochondrial
respiratory chain is necessary for S. cerevisiae to utilize proline as a nitrogen source [8].
Based on steady state kinetics, we propose that Put1p directly couples proline oxidation
to ubiquinone reduction in the electron transport chain.
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EXPERIMENTAL PROCEDURES
Materials
Ubiquinone-1 (CoQ1), flavin adenine dinucleotide (FAD), nicotinamide adenine
dinucleotide (NAD+), L-tetrahydro-2-furoic acid (L-THFA), succinic semialdehyde,
phenazine methosulfate, guanidium hydrochloride, antibiotics and buffers were
purchased

from

Sigma-Aldrich.

2,6-dichlorophenolindophenol

(DCPIP),

aminobenzaldehyde (o-AB), isopropyl β-D-1-thiogalactopyranoside (IPTG),

o-

sodium

chloride and Tris-HCl were purchased from Fisher Scientific Inc. L-proline was
purchased from Acros Organics Ltd. All other chemicals and buffers were purchased
from Sigma-Aldrich, Inc. Molecular size standards used for calibrating size exclusion
columns were purchased from Sigma. Bicinchoninic acid (BCA) reagent used for protein
quantitation was obtained from Pierce. All experiments used Nanopure water. D,L-P5C
was chemically synthesized from DL-hydroxylysine as described previously by Williams
and Frank and stored in 1M HCl at 4oC [22]. D,L-P5C contains equimolar concentration
of D-P5C and L-P5C.
Constructs
The PUT1 and PUT2 clones were a generous gift from Dr. Marjorie Brandriss at the
University of Medicine and Dentistry of New Jersey-New Jersey Medical School [23].
The genes were expressed from a pET14b expression vector containing N-terminal 6x his
tag. Put1p protein lacked the 18 residue mitochondrial signaling peptide (Put1p18).
Put2p was expressed as a full-length protein.
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Purification and characterization of Put1p and Put2p
Put1p18 and Put2p were expressed and purified from E. coli strain BL21(DE3)
pLysS with a N-terminal 6xHis tag using the pET14b expression vector as described
here. The pET14b-PUT118 and pET14b-PUT2 constructs were transformed into E. coli
BL21(DE3) pLysS. Transformed cells were plated onto Luria-Bertani (LB) agar
containing chloramphenicol (34 μg/ml) and ampicillin (50 μg/ml). Resulting colonies
were inoculated in 5 ml of LB broth containing the necessary antibiotics and grown to an
optical density at 600 nm (OD600) of 1.0. 1 ml of the LB culture was then used to
inoculate 1 L of Terrific Broth media containing chloramphenicol (34 μg/ml) and
ampicillin (50 μg/ml). The 1 L cultures were incubated at 37oC with shaking (250 rpm)
until OD600 of 0.8 at which point Put1p expression was induced with 0.5 mM IPTG
overnight at 20oC.
The overnight cultures were centrifuged at 6000 rpm for 20 min at 4oC. The resulting
pellets were resuspended in a final 50 ml volume of binding buffer (20 mM Tris, 5 mM
imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) supplemented with protease inhibitors (3
mM ε-amino-N-caproic acid, 0.3 mM phenyl methyl sulfonyl chloride, 1.2 μM leupeptin,
48 μM N-p-tosyl-L-phenyl alanine chloromethyl ketone, 78 μM N-α-tosyl-L-lysine
chloromethylketone). Additionally, 1 mM FAD and 0.5% n-octyl-β-D-glucoside was
supplemented for Put1p purification. The cell suspension was disrupted by sonication at
4oC for a total of 5 min (5 sec pulse on, 15 sec pulse off, 40% power). The cell extract
was centrifuged at 16000 rpm (4oC) for 60 min. The supernatant (50 ml) was passed
through a 0.8 μm filter (VWR) and applied to a Ni-NTA superflow (Qiagen) resin (25 ml
bed volume in a 2.8 cm x 30 cm column) equilibrated with 1X binding buffer. Wash
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buffer (125 ml, 20 mM Tris, 60 mM imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) was
then applied to the column followed by elution buffer (20 mM Tris, 500 mM imidazole,
0.5 M NaCl, 10% glycerol, pH 7.9) with a flow rate of 3 ml/min to elute protein fractions.
Fractions from the elution step were then analyzed by SDS-PAGE and pooled. Pooled
Put1p was then dialyzed into 50 mM Tris buffer (pH 8.1) containing 10% glycerol and
concentrated using an Amicon 30-kDa cutoff filter (Millipore). Put2p was dialyzed into
50 mM Tris buffer (pH 7.9) containing 25% glycerol.
The molar ratio of flavin to Put1p polypeptide was estimated by denaturing Put1p in 6
M guanidinium chloride. The spectrum was recorded from 600 to 250 nm. The total
amount of polypeptide was determined using the molar extinction coefficient of
denatured Put1p at 280 nm (A280= 45060 M−1cm−1) estimated by the ProtParam tool
(ExPASy Proteomics Server). The amount of flavin was determined using the molar
extinction coefficient for free FAD at 450 nm (A450= 11700 M−1 cm−1) in guanidinium
chloride [24]. The molar extinction coefficient of flavin bound to Put1p was estimated to
be 10800 M−1 cm−1 at 451 nm. The concentration of total Put1p protein was determined
using the BCA method [25] while the concentration of flavin-bound Put1p was
determined using the molar extinction coefficient for bound FAD (A451 = 10800 M−1
cm−1).
The oligomeric size of Put1p and Put2p were estimated using gel filtration
chromatography. Superdex-200 10/300 GL prepacked column (GE Healthcare) was
equilibrated with running buffer (50 mM Tris, pH 8, 150 mM NaCl). Purified Put1p and
Put2p were diluted to a concentration of 2 mg/ml in a volume of 250 µL in running
buffer. All samples and standards were spun at 10,000 rpm for 5 min prior to applying on
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column. The proteins were individually applied on the Superdex-200 column with a flow
rate of 0.5 ml/min at 4oC on a BioRad Biologic purification system (Lab of Dr. Joseph
Barycki, University of Nebraska-Lincoln). Elution of fractions was analyzed using A280
nm detection.
Steady-state kinetic measurements
Put1p kinetics

Put1p activity was measured at 25oC using terminal electron acceptors DCPIP,
oxygen and CoQ1. The concentrations of Put1p used for all of the kinetic assays are based
on the amount of flavin-bound Put1p. Proline:DCPIP oxidoreductase assay was
performed as described in a 1-ml reaction volume using Cary 100 and Cary 50 UVvisible spectrophotometers [26]. The DCPIP assay mixture contained 0.05 μM of Put1p
enzyme, 0.27 mM phenazine methosulfate, 75 μM DCPIP and proline concentrations
ranging from 0 to 300 mM in 20 mM Tris at pH 8.0. The rate of DCPIP reduction was
measured at 595 nm (ε = 16100 cm-1 M-1) [26]. Proline:O2 oxidoreductase activity (1 ml
assay volume) was measured in air saturated potassium phosphate buffer (50 mM, pH
8.0) using 1 μM Put1p, 4 mM o-AB and 0-300 mM proline at 443 nm by following the
formation of the o-AB-P5C yellow complex (ε = 2590 cm-1 M-1) [27]. Oxygen utilization
by Put1p was also measured using a Clark type Pt,Ag/AgCl-electrode. The reaction
mixture contained 2.2 µM Put1p and 300 mM proline in 50 mM phosphate buffer at pH
8.0 (25 °C).
CoQ1 reduction was measured using 0.1 μM Put1p in 50 mM phosphate buffer at pH
8.0 with 0-300 mM proline and 0-100 µM CoQ1. Reduction of CoQ1 was followed at 275
nm (ε= 13700 cm-1 M-1) using a 0.15 cm path length on a Hi-Tech Scientific SF-61DX2
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stopped-flow instrument at 25oC [28]. The kinetic parameters Km and kcat were estimated
by regression analysis of the initial reaction velocity versus proline concentration using
the Michaelis-Menten equation and Lineweaver-Burk plot analysis [29]. The binding
order of the Put1p proline:CoQ1 oxidoreductase reaction was evaluated using double
reciprocal plots of reaction velocity versus variable substrate concentrations. Assays were
performed in 50 mM potassium phosphate (pH 8.0) using 0. 2 µM Put1p and with proline
concentrations varied from 5-150 mM and CoQ1 concentrations varied 5-60 µM. Using
global curve fit analysis in SigmaPlot 11 software, data was fitted to a classical pingpong mechanism (Equation 3.1).

[ ]

[ ][ ]
[ ] [ ][ ]

Inhibition studies with L-THFA were performed using the DCPIP assay as described
previously [30]. For these assays, proline concentrations were varied from 0 – 200 mM
and the final L-THFA concentrations were varied from 0 – 6 mM using 100X stock
solutions of L-THFA in 50 mM Tris buffer (pH 8.0). The inhibition constant (Ki) for LTHFA was estimated by Dixon plot analysis [31]. For all of the above experiments, the
initial velocity values were the average from assays performed in duplicate or triplicate.
Proline titration of Put1p

Proline titrations of Put1p were performed at 20 °C in 50 mM Tris buffer (pH 8.0)
containing 50 mM NaCl and 10% glycerol under anaerobic conditions. The Put1p-proline
mixtures were equilibrated 5 min after each addition of proline prior to recording each
spectrum on a Cary 100 spectrophotometer. A correction for turbidity that occurred
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during the experiment was applied by subtracting a light scattering spectrum. The amount
of turbidity in each spectrum was determined by measuring the increase in absorbance at
700 nm due to scattering. The titration data were analyzed as previously described
assuming the formation of a reduced PutA-P5C complex [26, 32]. Although P5C is
hydrolyzed to the open GSA form, the ring and open chain forms are rapidly reversible
with P5C favored at pH > 7.0, indicating that P5C will be the predominant form at pH 8.0
[33].
Put2p kinetics

Put2p activity was measured by monitoring the formation of NADH at 340 nm (ε =
6400 cm-1 M-1[34]) at 25 °C. The assay buffer contained 50 mM potassium phosphate
(pH 7.5) and 25 mM NaCl. Put2p enzyme concentration was 0.4 µM (25.6 g/ml) and
NAD+ concentration was 0.2 mM. Varying concentrations of L-P5C ranging from 1 to
300 µM were used. Steady-state kinetics was also performed using 2-100 mM succinic
semialdehyde as an alternative substrate. Initial rates were fitted to a Michaelis-Menten
equation (equation 3.2).
[ ]
[ ]
pH dependence of Put1p and Put2p activity

The pH optimum for Put1p and Put2p activity was determined using a mixed buffer
system from pH 6.0–9.0 comprised of 20 mM each HEPES, MES, MOPS and TAB (80
mM total). Put1p activity was measured by Proline:DCPIP oxidoreductase assay using
0.1 µM Put1p and 220 mM proline. Put2p activity was measured by monitoring NADH
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formation as described above except using 0.27 µM Put2p and 70 µM L-P5C. Data were
fit to the equation :

where vlim is the limiting velocity (µmol/min) and pKa1 and pKa2 represent the acidic and
alkaline ionizations that contribute to the pH dependent curve of the reaction velocity.

RESULTS
Molecular properties of Put1p and Put2p
Purified Put1p lacking the N-terminal residues 1-18 (Put1p18) was shown by SDSPAGE to have an apparent molecular weight of 50 kDa (Figure 1A) which nearly
matches the predicted molecular weight of 53665 Da for the product of the N-terminal
6xHis Put1p18 construct. SDS-PAGE analysis showed that purified Put2p had an
apparent molecular weight of 64 kDa which is similar to its predicted molecular weight
of 64304 Da (Figure 1B). The oligomeric states of Put1p and Put2p were studied using
gel filtration chromatography. Figure 1C shows the elution profile of the two proteins.
Calculated molecular weight of Put1p in solution is 1,229,316 Da. Such a high molecular
weight is suggestive of aggregate formation in solution. The molecular weight of Put2p
was estimated to be 265,292 Da and is indicative of a tetramer in solution.
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Figure 1- Analysis of molecular weight of purified Put1p and Put2p. SDS-PAGE
analysis of A) Put1p (3 µg) and B) Put2p (15 µg) each purified from E. coli. Predicted
molecular weights of Put1p and Put2p are 53665 Da and 64304 Da, respectively. C)
Analysis of the oligomeric size of Put1p (solid black trace) and Put2p (solid blue trace)
by gel filtration chromatography. Using a plot of log10[molecular weight] versus elution
volume of molecular weight standards, the estimated oligomeric size of Put1p and Put2p
were 1,229,316 Da and 265,292 Da. For the molecular weight, Put1p is expected to be
aggregated in solution and Put2p is expected to be a homotetramer. Molecular size
standards are indicated as dotted curve. 1-thyroglobulin (Mr 669,000 Da), 2-ferritin (Mr
440,000 Da), 3-bovine serum albumin (Mr 67,000 Da), 4-carbonic anhydrase (Mr 29,000
Da) and 5-RNase A (Mr 13,700 Da).

84

Kinetic characterization
The UV-visible spectrum of Put1p is shown in Figure 2. Absorption maxima are at
355 and 450 nm with a shoulder at 478 nm and are indicative of a bound FAD cofactor to
the Put1p protein. (Figure 2, Inset A). Quantitation of the polypeptide at 280 nm and the
flavin at 451 nm indicates a flavin/polypeptide ratio of 0.43. The flavin/polypeptide ratios
varied from 0.3–0.45 between different preparations. Thus, recombinant Put1p contains a
significant amount of the apo-form. Addition of proline to Put1p resulted in reduction of
the flavin cofactor in a concentration dependent manner (Figure 2, Inset B). No anionic
semiquinone was observed indicating flavin semiquinone is not stabilized during proline

Figure 2- Spectral properties of purified Put1p. Put1p in 20 mM Tris–HCl buffer (pH
8.0) containing 100 mM NaCl and 0.25% octyl-glucoside. Concentrations of total and
flavin-bound Put1p protein are 16.1 and 7 μM, respectively. Inset A, flavin spectrum
from 550 to 300 nm of the same Put1p protein shown below. Inset B, titration of Put1p
(3.8 μM flavin-bound form) with proline in 50 mM Tris–NaCl buffer (pH 8.0). Curves 1–
5 are selected spectra from the titration at 0, 0.01, 0.200, 1.0, and 5 mM proline. Inset C,
best fit analysis of the absorbance decrease at 451 nm during the titration with proline
assuming the formation of a Put1p–P5C complex from which a Keq of 1.4 mM−1 proline
was estimated.
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reduction. 50% of the FAD in Put1p was reduced at 0.7 mM proline as estimated from
the plot shown in Figure 2 (Inset C).
Kinetic parameters for Put1p using the proline:DCPIP oxidoreductase assay were Km
= 36 ± 5 mM proline and kcat = 27 s-1. The Km value is similar to that reported for the
monofunctional TtPRODH enzyme (Km = 27 mM proline, kcat = 13 s-1) but the turnover
number is about 2-fold higher [20]. For PutA enzymes, Km values range from 100-150
mM proline with turnover numbers around 5-12 s-1 [35]. The kinetic parameters for Put1p
along with TtPRODH may indicate that monofunctional enzymes generally exhibit
higher turnover numbers and a lower Km values for proline than bifunctional PutA
enzymes.
Put2p kinetic parameters measured by NADH reduction indicate a Km of 104.2 ± 4.4
µM L-P5C and a turnover number (kcat) of 1.49 ± 0.26 sec-1. In comparison Thermus
thermophilus P5CDH has a Km of 42.7 ± 1.1 µM L-P5C and kcat of 0.52 ± 0.03 sec-1
(Chapter 2) and Human P5CDH has a Km of 31.6 ± 7.9 µM L-P5C and kcat of 10.0 ± 0.9
sec-1 [34].
pH dependence of Put1p and Put2p activity
The pH optimum for the Put1p reaction was determined by following proline:DCPIP
oxidoreductase activity over the pH range 6–9. Figure 3 shows a symmetrical and bellshaped curve for Put1p activity with a pH optimum of 8.25. By fitting the data to
equation 3.3, pKa values of 7.54±0.09 (pKa1) and 9.18±0.13 (pKa2) were estimated for the
two ionization events observed in the pH dependence of Put1p activity. Over a pH range
of 6-9, activity of Put2p also exhibited a symmetrical bell-shaped curve. However, a
more acidic pH optimum for Put2p activity was observed. The peak activity was seen at
7.15 and pKa values of 6.03±0.13 (pKa1) and 8.31±0.11 (pKa2) were estimated for the
ascending and descending limbs of the curve, respectively.

86

Figure 3- pH profiles of Put1p and Put2p enzymatic activity. The pH profile for the
Put1p reaction (black open circles) was determined by following proline:DCPIP
oxidoreductase activity using 0.1 µM Put1p and 220 mM proline over the pH range 6–9
at 25°C. Put2p activity was measured by NADH formation assay using 0.27 µM Put2p
and 70 µM L-P5C (blue closed circles). The pKa values for Put1p and Put2p were
estimated by fitting the data to equation 3.3. pKa values of 7.54±0.09 (pKa1) and
9.18±0.13 (pKa2) with a pH optimum of 8.25 were estimated for Put1p (black curve).
Put2p was estimated to have peak activity at 7.15 and pKa values of 6.03±0.13 (pKa1) and
8.31±0.11 (pKa2) (blue curve). pKa1 and pKa2 are the ionization constants for two
ionizable groups that influence the observed pH dependence of Put1p and Put2p activity.
Substrate specificity and inhibition
The ability of Put1p to use alternative substrate trans-4-hydroxy-L-proline and was
tested. Only very low activity (0.008 U/mg) was observed with 4-hydroxy-L-proline
which is more than 2000-fold lower than the specific activity of Put1p with proline (18
U/mg). ). Put1p also exhibited very low activity (0.004 U/mg) with L-pipecolic acid and
no activity with D-proline. Thus Put1p has strong substrate specificity for L-proline.
A potent inhibitor of PRODH activity is L-THFA, an isostructural analog of proline.
Previously, TtPRODH was shown to be inhibited by L-THFA with a Ki of 1 mM [20].
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Figure 4 shows a Dixon plot analysis of the inhibition of Put1p activity by L-THFA. The
plot is consistent with L-THFA acting as a competitive inhibitor of Put1p with a Ki of 5.5
mM. Most likely L-THFA binds to the active site of Put1p similarly to that observed in
the X-ray crystal structures of the E. coli PRODH domain complexed with L-THFA [36].

Figure 4- Inhibition of Put1p activity by L-THFA. A Ki value of 5.5 mM THFA was
estimated by Dixon plot analysis of the reaction velocity versus L-THFA at various
proline concentrations (0-200 mM).

The substrate for Put2p is open-chained GSA which is in a non-enzymatic
equilibrium with cyclic P5C. We wanted to test Put2p activity using an obligate openchain substrate such as succinic semialdehyde. Put2p exhibits a 15000-fold lower kcat/Km
with succinic semialdehyde (kcat/Km = 0.974 M-1 s-1 ) relative to P5C/GSA (kcat/Km =
14900 M-1 s-1) Thus, succinic semialdehyde is a relatively poor substrate for Put2p.
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Oxidative half-reaction
Because upregulation of human PRODH1 (or POX) activity leads to the formation of
reactive oxygen species and has important roles in apoptosis, we sought to characterize
the reactivity of Put1p with oxygen. The reactivity of Put1p with molecular oxygen or
oxidase activity was evaluated at different proline concentrations in air-saturated buffer
by monitoring P5C production with o-AB. Kinetic parameters for Put1p oxidase activity
were kcat = 0.8 min-1 and Km = 50 mM proline (Figure 5).
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Figure 5- Estimation of kinetic parameters using different electron acceptors. The
electron acceptors considered for catalytic turnover of Put1p were DCPIP, CoQ1 and
oxygen. Kinetic parameters for proline as substrate were measured using 75 μM DCPIP
(▼), 100 µM CoQ1(●) or air-saturated reaction buffer (○, Inset). The initial rates were
fitted to a Michaelis-Menten equation. The Km for proline using these electron acceptors
was comparable (36 mM, 59 mM and 50 mM for DCPIP, CoQ1, and oxygen
respectively). kcat for Put1p using artificial electron acceptor DCPIP and CoQ1were 27.6
sec-1 and 13.4 sec-1. Put1p exhibited negligible turnover using molecular oxygen (kcat =
0.013 sec-1).
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Put1p displayed similar activity in assays using an O2 electrode in which Put1p depleted
oxygen at a rate of 0.54 min−1. The turnover number with molecular oxygen is 15-fold
lower for Put1p than TtPRODH (12 min-1) [20].
The Put1p oxidative half-reaction was then characterized using CoQ1 as the electron
acceptor. The kcat and Km values determined with CoQ1 were 20 ± 1 s-1 and 57 ± 6 µM,
respectively. The kinetic parameters for proline with CoQ1 concentration held constant
(100 µM) were estimated to be kcat = 13.4 ± 0.2 s-1 and Km = 59 ± 3 mM proline. The high
turnover rate of Put1p with CoQ1 suggests ubiquinone is the most likely the physiological
electron acceptor for Put1p. The order of the reaction was then analyzed by varying
proline concentration at different CoQ1 concentrations. Figure 6 shows double reciprocal
plots of the reaction velocity versus proline (Figure 6A) and CoQ1 (Figure 6B). The data
in both plots could be fit with parallel slopes indicating a ping-pong mechanism (Scheme
2) in which no ternary complex is required during catalytic turnover with proline and
ubiquinone.

Figure 6- Binding order analysis of Put1p with proline and CoQ1. Panel A shows a
double reciprocal plot of velocity versus proline at four different CoQ1 concentrations (5,
10, 20, and 60 µM). Panel B shows a double reciprocal plot of velocity versus CoQ1 at
four different proline concentrations (5, 20, 50, and 150 mM). Assays were performed in
50 mM potassium phosphate (pH 8.0) at 25oC. Data were fit by global curve fitting to a
linear polynomial equation with a shared slope parameter (R2 values of 0.95 and 0.97).
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Scheme 2- Schematic representation of binding order of CoQ1 and proline with
Put1p
DISCUSSION
Sequence comparisons among bacterial PutA/PRODHs, Put1p, and human PRODH
predict that a number of residues important for substrate and FAD binding in the PRODH
catalytic core are conserved [20]. The sequence similarity between Put1p (476 amino
acids) and the PRODH domain of EcPutA (1-669 residues) is 39%. Put1p and human
PRODH1 have 25% sequence identity and 41% similarity consistent with a shared
PRODH domain and a catalytic core structure. Nine conserved motifs important for
substrate (1-3, 7-9) and FAD binding (4-6) have been identified in the PRODH domain of
bacterial PutA and monofunctional PRODH enzymes [20]. Of these, motifs 3, 8, and 9
are strongly conserved in Put1p. Figure 7 shows a sequence alignment of motifs 3, 8 and
9 in Put1p and EcPutA. Conserved residues in these motifs which are critical for proline
binding in EcPutA include Asp370, Tyr540, Arg555, and Arg556 (Asp257, Tyr430,
Arg445, and Arg446 in Put1p). Important residues for FAD binding are also conserved in
Put1p. These residues are found in motifs 4-6 and in EcPutA include Gln404 (Gln 294,
Put1p) that forms a hydrogen bond with the FAD O(2), Arg431 which hydrogen bonds to
the N(5) of FAD (K321, Put1p), and His487 (His377, Put1p) that interacts with the FAD
pyrophosphate [20]. Another important residue for FAD binding in EcPutA is Glu559
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(motif 9) which hydrogen bonds to the ribityl 3′-OH and is conserved in Put1p
(Glu449). Lastly, Put1p is predicted to have the α5a helix that is a unique feature of the
(βα)8 barrel in EcPutA. In EcPutA, Trp438 (motif 5) from the α5a helix stacks against the
adenine ring of the FAD. The corresponding residue in Put1p is Ile328 which would
serve a similar purpose of providing non-polar interactions with the adenine ring.

Figure 7- Alignment of PRODH domain sequence motifs between E. coli PutA
(EcPutA), Human PRODH (hPRODH1) and Put1p. Conserved residues with critical
roles in proline and FAD interactions as mentioned in the text are underlined. Alignment
was performed using GeneDoc software and the EcPutA (AAB59985), hPRODH1
(NP_057419.4), and Put1p (NP_013243) sequences.

Put1p activity with other secondary amine compounds was tested to explore how
strongly L-proline is the preferred substrate. Humans have two PRODH enzyme forms
that share 45% sequence identity, PRODH1 (NM_016335) which is specific for Lproline, and PRODH2, (NM_021232) which is specific for trans-4-hydroxy-L-proline.
PRODH2 (OH-PRODH) catalyzes the oxidation of trans-4-hydroxy-L-proline to ∆1pyrroline-3-hydroxy-5-carboxylate [37, 38]. ]. Humans also have the enzyme, Lpipecolic acid oxidase, which converts L-pipecolic acid to Δ1-piperideine-6-carboxylic
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acid. Because S. cerevisiae encodes only one PRODH gene, we were interested to see
whether Put1p exhibited a broad substrate specificity that could accommodate variations
in the five-membered pyrrolidine ring.
Conserved among all bacterial PutA/PRODH enzymes is an active site Tyr residue
(Tyr540 in EcPutA) that helps shape the proline binding site [37]. Interestingly, human
PRODH1 and HO-PRODH differ at this corresponding residue with the Tyr replaced by
a smaller Ser residue in HO-PRODH [37]. Recently, Ostrander et al. provided evidence
that Tyr540 in EcPutA imposes spatial constraints in the active site that determines the
preference for proline over hydroxyproline [37]. Substitution of Tyr540 with Ser or Ala
in EcPutA decreased the preference for proline by > 20-fold suggesting the corresponding
Ser residue in HO-PRODH allows utilization of both proline and hydroxyproline [37]. As
noted above Put1p is predicted to share the corresponding Tyr residue (Tyr430, motif 8)
found in bacterial PutA/PRODH enzymes and human PRODH1. Accordingly, Put1p
exhibits a strict preference for proline over hydroxyproline (2000-fold) consistent with
the active site Tyr residue helping to define substrate specificity. Other lower organisms
that lack a specific OH-PRODH enzyme, have hydroxyproline epimerases that catalyze
the conversion of hydroxy-L-proline to hydroxy-D-proline [38-40]. Hydroxy-D-proline is
then oxidized to ∆1- pyrroline-4-hydroxy-2-carboxylate by hydroxy-D-proline oxidase
[38-40]. S. cerevisiae does not contain this pathway for hydroxyproline. The ability of
microorganisms to utilize hydroxy-L-proline can provide important metabolic advantages
in pathogen- and symbiotic-host interactions in mammals and plants [38-41]. Recently, a
hydroxyproline transport system was identified in the soil microbe Sinorhizobium
meliloti, the first to be described in a prokaryote [41].
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Succinic semialdehyde is four-carbon aldehyde that lacks an α–amino group.
Upon testing the possibility of succinic semialdehyde as a substrate for Put2p, we found
that Put2p exhibits a 15000-fold lower catalytic efficiency relative to P5C/GSA. Analysis
of T.thermophilus P5CDH structure with glutamate bound to the active site (PDB ID:
2BHQ) reveals several possible ionic interactions of the α-carboxylate and amine groups
of glutamate with residues in the TtP5CDH active site. The α-carboxylate group of
glutamate is 3 Å from the backbone amide nitrogen of Gly 477 and Ala 488. The αcarboxylate moiety is also within hydrogen bonding distance (2.7 Å) to Ser 323. These
active site residues appear to be well conserved in Put2p and other P5CDH’s including
human P5CDH and bifunctional PutA from Bradyrhizobium japonicum. Similar
interactions might be possible in the Put2p active site. Shortage of one carbon atom in the
aliphatic succinic semialdehyde may lead to lack of stabilizing interactions in the active
site, thereby allowing Put2p to select appropriate substrate for the proline oxidative
pathway.
The oxidative half-reaction of Put1p was investigated to provide molecular insights
into the mitochondrial functions of human PRODH. A comparison of the Put1p and
human PRODH1 sequences reveals a 25% sequence identity (41% similarity) consistent
with a shared (βα)8 PRODH domain and a catalytic core structure. Put1p exhibited low
reactivity with molecular oxygen and high activity with ubiquinone during catalytic
turnover with proline. How adequately these results address the properties of human
PRODH are not yet clear. Despite a high degree of similarity, Put1p and human PRODH
may have fundamental differences in the oxidative half-reaction step. The ability of
human PRODH to contribute to both mitochondrial energetics and apoptosis may be a
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key distinctive feature of this enzyme. Human PRODH may have significant reactivity
with molecular oxygen which would explain its role in generating mitochondrial reactive
oxygen species and apoptosis. A useful comparison that has been used to describe
PRODH reactivity in air is the ratio of the turnover numbers from the proline
oxidoreductase assays using DCPIP and oxygen as electron acceptors (DCPIP/O 2). The
DCPIP/O2 activity ratio for Put1p is > 2000 and is similar to the value for EcPutA (>
2500). In contrast, TtPRODH has a DCPIP/O2 activity ratio of 61 indicating less
preference for DCPIP over oxygen. Also, PutA from Helicobacter pylori was reported to
have a DCPIP/O2 activity ratio of 16 [42]. Structural insights into the variation of oxygen
reactivity among PutA/PRODH enzymes are still lacking but the differences in oxygen
reactivity observed among PRODH enzymes is likely a consequence of diverse
environmental niches and unique physiological roles for proline metabolism such as the
programmed cell death pathway in mammals.
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CHAPTER 4
Studying the effect of solvent pH on
channeling of intermediate Δ1–
pyrroline-5-carboxylate in PutA
from Bradyrhizobium japonicum
Note: This chapter contains methodology published in the research article: “Crystal
structure of the bifunctional proline utilization A, flavoenzyme from Bradyrhizobium
japonicum.” Srivastava D, Schuermann JP, White TA, Krishnan N, Sanyal N, Hura GL, Tan A,
Henzl MT, Becker DF, Tanner JJ. Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2878-83.
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INTRODUCTION
Proline utilization A (PutA) from Bradyrhizobium japonicum (BjPutA) is a
bifunctional enzyme containing two catalytic domains- proline dehydrogenase (PRODH)
and ∆1-pyrroline-5-carboxylate dehydrogenase (P5CDH) [1]. This type of multi-domain
organization of proline catabolic enzymes in B. japonicum is also observed in other
Gram-negative bacteria [2]. The oxidation of proline to glutamate is catalyzed in
consecutive reactions by PRODH and P5CDH (Scheme 1). In the first step, proline
dehydrogenase (PRODH; EC 1.5.99.8) uses a flavin adenine dinucleotide (FAD) cofactor
as an electron acceptor to remove two electrons from proline, rendering the intermediate
∆1-pyrroline-5-carboxylate (P5C).

P5C then undergoes a non-enzymatic hydrolysis,

which opens the ring structure and generates γ-glutamate semialdehyde (GSA). P5C
dehydrogenase (P5CDH; EC 1.5.1.12) next pulls off two additional electrons from GSA
using nicotinamide adenine dinucleotide (NAD+) to complete the conversion of proline to
glutamate [3]. Avoiding release of P5C/GSA into bulk solvent during proline oxidation
may be beneficial due to the chemical properties of P5C/GSA as discussed in Chapter 1.

Scheme 1 – Reactions catalyzed by the PRODH and P5CDH domains of BjPutA

Recently, Srivastava et al reported a 2.1 Å resolution crystal structure of BjPutA
(999-residue polypeptide) that reveals an interior channel connecting the PRODH and
P5CDH active sites [4] (PDB ID: 3HAZ) (Figure 1A). Supporting kinetic studies have
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demonstrated that BjPutA transfers the intermediate P5C/GSA from the PRODH active
site to the P5CDH active site. The dimeric structure of BjPutA seems to be critical for
sealing the channel and minimizing access to bulk solvent. A β-flap protrudes from the
P5CDH domain (β-strands, residues 628-646 and 977-989) from one protomer and forms
intermolecular interactions with the P5CDH domain of the second protomer (Figure 1B).

B

A
FAD
Isoalloxazine
-flap

Catalytic
Arg456

Potential
openings

Catalytic
Cys792

NAD+

C
Figure 1- Overall structure of dimeric BjPutA and structural role of the C-terminal
β-flap region. A) Ribbon representation of dimeric BjPutA. The PRODH domain (red)
and the P5CDH domain (orange) of each protomer are connected by a linker region
(green). Active site residues (Arg456, Cys792), FAD and NAD+ are displayed as sticks.
-flap of each protomer is colored as magenta. The substrate channel of each BjPutA
protomer is shown as a blue surface. B) Close-up view of the dotted section of the dimer
showing the C-terminal region of the β-flap. C) Surface representation of the β-flap
region showing potential openings that lead to the internal channel of BjPutA. The
figures were made using PyMol [5] and PDB ID: 3HAZ.
Figure 1C shows that in BjPutA the β-flap not only helps stabilize dimer
formation but is also important for sealing the central cavity. There appears to be two
adjacent openings near the β-flap that may allow access between external solvent and the
internal channel. To study the extent to which the substrate channel is closed off from
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bulk solvent for transfer of P5C and its hydrolysis to GSA, we used a truncated variant of
BjPutA. Residues 987-999 of the C-terminal region of the β-flap were deleted to test
whether bulk solvent access to the channel could be increased (Scheme 2). The truncated
BjPutA 1-986 mutant is expected to exhibit less channeling of P5C/GSA due to
potentially increased exposure of the channel cavity to bulk solvent. The overall
PRODH/P5CDH coupled reaction in the BjPutA 1-986 mutant may also become more
sensitive to the bulk solvent environment (e.g., pH) relative to wild-type BjPutA.

Channeling
(Wild type BjPutA)

E1

A

Partial Channeling
(BjPutA 1-986  -flap mutant )

E1

E2
B

C

A

Non-channeling control
(Mixed Variants)
Cys 792 Ala

E2
B

C

A

E1

E1

B

B

E2

E2

C

Arg 456 Met

Scheme 2- Schematic representation of enzymes used for comparing substrate
channeling in bifunctional enzymes. E1 and E2 represent PRODH and P5CDH
respectively. A, B and C represent proline, P5C/GSA and glutamate respectively.

In the proline catabolic pathway, channeling of P5C/GSA may be important for
making the hydrolysis of P5C to GSA more favorable at physiological pH values. The
P5C/GSA equilibrium is highly pH dependent.

Bearne and Wolfenden have

demonstrated by nuclear magnetic resonance that GSA is favored at pH < 6.6 due to
protonation of the pyrrolinium ring, which facilitates the hydrolysis of P5C to GSA
(Figure 2). Thus, one benefit of channeling between PRODH and P5CDH would be to
increase the pKa of the pyrrolinium species above pH 6.6, making the hydrolysis of P5C
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to GSA more favorable at physiological pH conditions. If we only consider the P5C/GSA
hydrolysis step, substrate channeling is likely more critical for the proline catabolic
pathway than for proline biosynthesis, since P5C formation is favored at physiological
pH.

Figure 2- pH dependent hydrolysis of ∆1-pyrroline-5-carboxylate (P5C) to γglutamate semialdehyde (GSA). Ratio of the hydrate of GSA to the imine of P5C as a
function of pD obtained from a proton NMR spectra [6]. The pKa of the imine proton was
calculated as 6.67 (±0.08). Figure adapted from [6].

To test this hypothesis, we examined the pH dependence of the coupled PRODHP5CDH reaction (channeling assay). Using proline as the substrate for the channeling
reaction, we measured the P5CDH enzymatic rate (reflected by rate of NADH formation)
and the transient time required to attain steady-state NADH formation under varying pH
conditions. If the substrate channel provides a favorable condition for hydrolysis of P5C,
the transient time for a channeling reaction should remain unaffected by external pH in
the wild-type enzyme. BjPutA 1-986 is expected to be influenced by external pH to a
greater extent due to more exposure of the substrate channel to bulk solvent than wild-
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type BjPutA. Because cyclic P5C is favored at pH above 6.6, the transient time for
glutamate formation may to increase substantially for BjPutA 1-986 at higher pH values.
We also used a non-channeling control which is an equimolar mixture of BjPutA active
site mutants that lack PRODH (R456M) and P5CDH (C792A) activity [4]. The R456M
mutation inactivates PRODH but does not impair P5CDH activity, whereas the C792A
mutation inactivates P5CDH but does not impair PRODH activity. In this non-channeling
control, P5C formed by the C792A variant must diffuse out into bulk solvent and bind to
the R456M variant before NADH is formed. Hence, for the non-channeling control, the
hydrolysis of P5C to GSA should be highly dependent on the pH of the bulk solvent.

EXPERIMENTAL PROCEDURES
Materials
D,L-P5C was chemically synthesized from D,L-hydroxylysine as described
previously by Williams and Frank and stored in 1 M HCl at 4oC [7]. Synthesized D,LP5C is an equimolar mixture of D-P5C and L-P5C. All chemicals were purchased from
Sigma Aldrich unless noted otherwise. Tris(3-hydroxypropyl)phosphine (THP) was
purchased from Santa Cruz Biotechnology Inc. CoQ1 reduction assays and substrate
channeling assays were carried out on a SF-61DX2 stopped-flow spectrophotometer
(TgK Scientific, UK). CoQ1 reduction assays for enzymatic activities of PRODH and
P5CDH activity assays were carried out on a Cary-50 UV-Vis spectrophotometer
(Varian) or Powerwave XS Microplate reader (BioTek). The pKA8H-BjPutA 1-986construct was a generous gift from Dr. John tanner (University of Missouri, Columbia).
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Purification of BjPutA and mutants
Wild-type BjPutA, BjPutA mutants R456M, C792A and, BjPutA 1-986 C-terminal
deletion mutant were expressed and purified from E. coli strain BL21(DE3) pLysS with
an N-terminal 6xHis tag using the pKA8H expression vector [4]. The BjPutA-pKA8H
constructs were transformed into E. coli BL21(DE3) pLysS. Transformed cells were
plated onto Luria-Bertani (LB) agar containing chloramphenicol (34 μg/ml) and
ampicillin (50 μg/ml). Resulting colonies were inoculated in 5 ml of LB broth containing
the necessary antibiotics and grown to an optical density at 600 nm (OD600) of 1.0. 1 ml
of the LB culture was then used to inoculate 1 L of LB Broth media containing
chloramphenicol (34 μg/ml) and ampicillin (50 μg/ml). The 1 L cultures were incubated
at 37oC with shaking (250 rpm) until OD600 of 0.8 at which point protein expression was
induced with 50 µM IPTG overnight at 20oC.
The overnight cultures were centrifuged at 6000 rpm for 20 min at 4oC. The resulting
pellets were resuspended in a final 50 ml volume of binding buffer (20 mM Tris, 5 mM
imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) supplemented with 1 mM FAD and
protease inhibitors (3 mM ε-amino-N-caproic acid, 0.3 mM phenyl methyl sulfonyl
chloride, 1.2 μM leupeptin, 48 μM N-p-tosyl-L-phenyl alanine chloromethyl ketone, 78
μM N-α-tosyl-L-lysine chloromethylketone). The cell suspension was disrupted by
sonication at 4oC for a total of 5 min (5 sec pulse on, 15 sec pulse off, 40% power). The
cell extract was centrifuged at 16000 rpm (4oC) for 60 min. The supernatant (50 ml) was
passed through a 0.8 μm filter (VWR) and applied to a Ni-NTA superflow (Qiagen) resin
(25 ml bed volume in a 2.8 cm x 30 cm column) equilibrated with 1X binding buffer.
Wash buffer (125 ml, 20 mM Tris, 60 mM imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9)
was then applied to the column followed by elution buffer (20 mM Tris, 500 mM
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imidazole, 0.5 M NaCl, 10% glycerol, pH 7.9) with a flow rate of 3 ml/min to elute
protein fractions. Fractions from the elution step were then analyzed by SDS-PAGE and
pooled. Pooled protein was then dialyzed into 50 mM Tris buffer (pH 7.9) containing 50
mM NaCl, 0.5 mM EDTA, 0.5 mM THP, 10% glycerol and concentrated using an
Amicon 100-kDa cutoff filter (Millipore) and stored in -80oC.
The absorbance spectra of purified protein were recorded from 600 to 250 nm. The
concentration of flavin was determined using the molar extinction coefficient for
enzyme-bound FAD at 450 nm (A450= 13700 M−1 cm−1) [1]. Any unbound flavin was
removed by passing purified protein through a PD-10 desalting column (GE Healthcare).
The concentration of total protein was determined using Pierce 660 reagent [8]. The ratio
of flavin concentration to protein concentration was used to determine the amount of
BjPutA containing bound FAD. The concentration of FAD bound BjPutA was used as the
concentration of BjPutA in the enzyme assays.
Enzymatic assay of BjPutA and mutants
PRODH kinetics
Kinetics of the PRODH domain of BjPutA and its variants were determined by
following the reduction of CoQ1. CoQ1 reduction was measured using 0.5 μM of BjPutA
(wild-type BjPutA and mutants) in 50 mM phosphate buffer at pH 8.0. Kinetic
parameters for proline were measured by varying proline (0-250 mM) with fixed CoQ1
concentration (250 µM). Kinetic parameters for CoQ1 were measured by varying CoQ1
(0-300 µM) with fixed proline concentration (150 mM). Reduction of CoQ1 was followed
at 275 nm (ε=13700 cm-1 M-1) using a 0.15 cm path length on a Hi-Tech Scientific SF61DX2 stopped-flow instrument at 25oC [9]. The kinetic parameters Km and kcat were
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estimated by regression analysis of the initial reaction velocity versus proline or CoQ 1
concentration using the Michaelis-Menten equation. The specific activity of PRODH
with 40 mM proline as the substrate was determined by measuring P5C complex
formation

with

o-aminobenzaldehyde

(o-AB)

[10].

P5C

forms

a

yellow

dihydroquinazolinium complex with o-AB, which is detected by absorbance at λ = 443
nm (ε=2900 M-1cm-1 [10]). For this assay, wild type BjPutA (0.18 µM) or BjPutA 1-986
(0.18 µM) was incubated with proline (40 mM), o-AB (4.0 mM) and 0.1 mM CoQ1 as an
electron acceptor. The assays were performed at pH 6-10 using a mixed buffer system
containing 50 mM potassium phosphate, 25 mM borate and 25 mM bicine buffer. Data
were fit to the equation 4.1.

where vlim is the maximal velocity and pKa1 and pKa2 represent the acidic and alkaline
ionizations that contribute to the pH dependent curve of the reaction velocity.
P5CDH kinetics
The P5CDH activity of wild-type BjPutA, BjPutA R456M and BjPutA 1-986 was
measured by monitoring the formation of NADH at 340 nm (ε = 6400 cm-1 M-1 [4]) at 25
°C. The assay buffer contained 50 mM potassium phosphate (pH 7.5), 25 mM borate and
25 mM bicine. Enzyme concentration was 0.18 µM (20 µg/ml) and NAD+ concentration
was 0.2 mM. Varying concentrations of L-P5C ranging from 1 -3.9 mM were used. Initial
rates were fitted to the Michaelis-Menten equation. For obtaining pH profile of kinetic
parameters, P5CDH activity assays were carried out in a mixed buffer system containing
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50 mM potassium phosphate, 25 mM borate and 25 mM bicine buffer pH 6-10 was used.
kcat/Km for P5CDH were fit to the equation 4.1.
Substrate channeling assays at varying pH
To determine the pH activity dependence of substrate channeling, NADH
formation was monitored at 340 nm in assays performed at 23 °C containing proline (40
mM), BjPutA (0.18 µM), CoQ1 (0.1 mM), and NAD+ (0.2 mM) in buffer containing 50
mM potassium phosphate, 25 mM borate and 25 mM bicine (pH 6-10). Identical assays
were performed using 0.18 µM (20 μg/ml) BjPutA 1-986 or an equimolar mixture of the
BjPutA variants C792A and R456M (0.18 µM or 20 μg/ml final concentration each).
Spectral interference caused by changes in CoQ1 absorbance at 340 nm was corrected for
by subtracting progress curves from assays performed under identical conditions in the
absence of NAD+.
The progress curve for two non-interacting PRODH and P5CDH enzymes was
simulated as described previously [11] for a diffusion-limited two-enzyme model using
equations 4.2 and 4.3

[

]

( )

(

)

In the above equation, v1 is the experimentally determined rate of PRODH activity under
the specified assay conditions with 40 mM proline, t is time in sec, Km2 and v2 are the
steady-state Michaelis-Menten constants for P5CDH activity in BjPutA wild-type and
mutants, and τ is the transient time (sec) required to attain steady-state formation of
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product (i.e., NADH). The transient time was also calculated by extrapolating the linear
NADH formation rate to the x-axis. The x-intercept reflects the transient time required
for reaching steady-state NADH formation. pH dependent changes in transient time were
fitted to equation 4.4,

where Tobs represents the observed extrapolated transient time, Tlim1 and Tlim2 represent
the limiting values for transient time at low and high pH respectively and pKa is the acid
dissociation constant of an ionizable group in the pH range.
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RESULTS
Kinetic properties of wild-type BjPutA and its mutants
Wild type BjPutA, BjPutA 1-986 and inactive mutants C792A and R456M were
purified with over 90% protein bound to FAD in all cases. Each protein displays a typical
UV-visible spectrum of protein bound FAD with maximum absorbance peaks at 384 and
450 nm and a shoulder near 467 nm (Figure 3) [12].

2.0

WT BjPutA
BjPutA 1-986
BjPutA R456M
BjPutA C792A

Absorbance

1.5

1.0

0.5

0.0
300

400

500

600

Wavelength (nm)
Figure 3- Absorbance spectra of purified BjPutA enzymes. Wild-type BjPutA,
BjPutA 1-986, active site mutants C792A and R456M show similar flavin spectra. The
shoulder at 467 nm is characteristic of flavin bound to the PRODH active site of BjPutA.
The steady-state kinetic parameters of BjPutA wild-type and the mutants are
reported in Table 1. The kinetic parameters for proline using CoQ1 as an electron
acceptor are 28.6 ± 3.8 mM proline (Km) and 1.69 ± 0.06 sec-1(kcat). These values are
similar to the previously reported parameters (Km = 31 ± 6 mM proline, kcat = 2.0 ± 0.1
sec-1) for BjPutA [4]. BjPutA 1-986 was shown to have a Km of 40.6 ± 2.7 mM proline
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and a two-fold higher kcat of 3.47 ± 0.07 sec-1 relative to wild-type BjPutA. The BjPutA
mutant C792A also shows PRODH activity similar to wild-type BjPutA whereas the
R456M mutant is devoid of PRODH activity (Table 1).
CoQ1 has been shown to act as a potential physiological electron acceptor for the
PRODH activity of E. coli PutA (EcPutA) [13], monofunctional PRODH from S.
cerevisiae (Put1p) [14] and T. thermophilus (TtPRODH) (Chapter 2). Although CoQ1 has
been previously used in assays with BjPutA [4], its steady-state kinetic parameters have
not yet been determined. Here, we report that wild-type BjPutA has a Km of 83.63 ±
13.41 µM CoQ1. In comparison, EcPutA has a Km of 110 ± 15 µM for CoQ1.
Monofunctional PRODHs exhibit a somewhat wider range of Km values for CoQ1 with
Put1p and TtPRODH having Km values of 57 ± 6 µM and 162.2 ± 7.6 µM CoQ1,
respectively. The Km values for CoQ1 with BjPutA 1-986 (72.41 ± 4.96 µM) and BjPutA
P5CDH inactive mutant C792A (103.01 ± 20.83 µM) are similar to wild-type BjPutA.
Table 1 – Steady-state kinetic parameters of PRODH and P5CDH activities of
BjPutA wild-type and mutants
Domain

PRODH
Proline

Substrate
Km
(mM)

WT
BjPutA
BjPutA
R456M

P5CDH

28.6

3.8

ND

kcat
(sec-1)

1.69

0.06

ND

CoQ1
kcat/Km
(M-1 sec-1)

Km
(µM)

5.9 x 101

83.63
13.41

ND

ND

kcat
(sec-1)

1.59

0.09

ND

L-P5C
kcat/Km
(M-1 sec-1)

kcat
(sec-1)

kcat/Km
(M-1 sec-1)

1.9 x104

1.35

0.16

3.45

0.18

2.6 x 103

ND

1.62

0.21

3.44

0.21

2.1 x 103

BjPutA
C792A

60.1

10.1

1.58

0.09

2.6 x 101

103.01
20.83

1.39

0.12

1.4 x 104

BjPutA 1986

40.6

2.7

3.47

0.07

8.5 x 101

72.41
4.96

3.54

0.08

4.9 x 104

ND- No Activity detected.

Km
(mM)

ND

1.13

0.13

ND

3.26

0.16

ND

2.88 x 103
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The P5CDH kinetic parameters of wild-type BjPutA (Km = 1.35 ± 0.16 mM L-P5C, kcat =
3.45 ± 0.18 sec-1) and BjPutA 1-986 (Km = 1.13 ± 0.13 mM L-P5C, kcat = 3.26 ± 0.16
sec-1) are nearly identical (Table 1). The R456M mutant exhibits P5CDH activity similar
to that of wild-type BjPutA (Table 1). As anticipated, the C792A mutant has no P5CDH
activity.
Substrate channeling assays
A common strategy to test for channeling is to evaluate whether there is a lag time
in reaching steady-state formation of the final product in a coupled assay. Figure 4 shows
the substrate proline being converted to the final product glutamate (reflected by
concomitant NADH formation) via the coupled action of PRODH and P5CDH domains
of BjPutA. With wild-type BjPutA, steady-state formation of NADH occurs without any
apparent lag time. However, the progress curve can be fitted to equation 4.2 for a twoenzyme model to yield a lag time of 10 sec. The near absence of a lag time in the
approach to steady-state is indicative of substrate channeling. Fitting the reaction
progress curve for the non-channeling enzyme pair C792A and R456M to equation 4.2
estimates a lag time of 7.8 min. The lag time determined by extrapolation of the linear
NADH formation rate is somewhat shorter at 5.3 min. In contrast to wild-type BjPutA,
BjPutA 1-986 exhibits a noticeable lag time of about 2.5 min by extrapolating from the
steady-state linear phase of the reaction. Fitting the progress curve to equation 4.2 yields
a lag time of 2.4 min. The observation of a lag in NADH formation with BjPutA 1-986
indicates that deletion of C-terminal residues 987-999 diminishes substrate channeling.
However, the lag time is only 50% of the non-channeling control suggesting that to some
extent substrate channeling is still occurring.
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Figure 4- Transient time analysis of BjPutA and channeling variants. Colored solid
lines represent the time-course of NADH formation for BjPutA, BjPutA 1-986 and nonchanneling mixed variants C792A and R456M using 40 mM proline, 0.1 mM CoQ1 and
0.2 mM NAD+ as substrates and 0.18 µM of each enzyme. Colored dashed lines represent
extrapolation of linear rate of NADH formation to the x-axis. The estimated lag time (xintercept) from the extrapolations are 2.5 min and 5.3 min for BjPutA 1-986 and nonchanneling mixed variants C792A and R456M,, respectively. The black dotted lines
overlapping each trace of NADH formation are the fitting of the reaction progress curve
with the two-enzyme model (equation 4.2). The estimated transient times from the fitting
are 10 sec, 2.4 min, and 7.8 min for wild-type BjPutA, BjPutA 1-986 and mixed variants
C792A and R456M, respectively.

pH activity dependence of substrate channeling
We next wanted to test the effect of pH on substrate channeling and explore the
pH dependent hydrolysis of P5C as previously discussed. Channeling assays were
performed for wild-type BjPutA, BjPutA 1-986 and the mixed variants (C792A and
R456M) from pH 6-10. Figure 5A shows the time-course of NADH formation using 40
mM proline as the initial substrate for wild-type BjPutA. A plot of NADH formation
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Figure 5- pH activity dependence of NADH formation. A) Time-course of
NADH formation by wild-type BjPutA pH 6-9.5. B) Plot of the steady-state linear rates
of NADH formation versus pH for wild-type BjPutA, mutant 1-986, and mixed variants
(C792A and R456M). 50 mM potassium phosphate, 25 mM borate and 25 mM bicine
mixed buffer system was used to generate a pH range of 6 to 10.
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versus pH (Figure 5B) shows that the rate of NADH formation reaches a maximum at pH
6.5 and steadily declines with increased pH. BjPutA 1-986 shows an identical
dependence on pH (Figure 5B). The mixed BjPutA mutants show a similar pH
dependence as well except that NADH formation peaks at pH 7 (Figure 5B). The rates for
NADH formation are similar for each BjPutA enzyme at pH 6.0 with 1.92 µM/min, 2.11
µM/min and 2.0 µM/min for wild-type BjPutA, BjPutA 1-986 and mixed variants
respectively. These rates decrease by 8-9 fold at pH 10.0. Next, the lag time for NADH
formation was plotted as a function of pH (Figure 6).

Figure 6- pH dependence of transient time in the BjPutA channeling reaction.
Transient time is extrapolated from the linear rate of NADH formation and plotted
against pH. The change in transient time is fitted to equation 4.4 using SigmaPlot 12
(Systat Inc.). The solid line, dotted line and dashed line correspond to the fit for BjPutA,
BjPutA 1-986 and mixed variants with pKa values of 8.64, 8.70 and 8.53 respectively.
The lag time remains unchanged within the pH range 6 to 8 for wild-type BjPutA,
BjPutA 1-986 and the mixed variants. Within this pH range, wild-type BjPutA exhibits
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approximately no lag in NADH formation, whereas BjPutA 1-986 and mixed variants
show lag times of about 2.5 min and 6 min, respectively. Above pH 8 there is a drastic
increase in the lag time to an equal extent for all three enzymes. A plateau is reached
above pH 9, with apparent lag times of 17-23 min for the different BjPutA enzymes.
Figures 5 and 6 show that wild-type BjPutA, BjPutA 1-986, and the mixed variants
exhibit similar pH profiles of NADH formation.
Effect of pH on PRODH and P5CDH domains of BjPutA
To further probe the factors influencing the pH dependence of NADH formation
in BjPutA, we examined the effect of pH on the individual PRODH and P5CDH
activities. The PRODH specific activity of wild-type BjPutA , BjPutA 1-986, and the
mixed variants was measured at different pH values. These assays used 40 mM proline
and 0.1 mM CoQ1 similar to the channeling assays shown in Figures 4 and 5 [4]. Figure 7
shows the dependence of PRODH activity on pH.

Figure 7- pH profile of PRODH specific activities. Specific activities of PRODH from
BjPutA, BjPutA 1-986 and C792A measured by production of o-AB-P5C complex at 443
nm. The pH profiles were fit to equation 4.1 in SigmaPlot 12 (Systat Inc.). The solid line,
dotted line and dashed line correspond to the fit for BjPutA, BjPutA 1-986 and C792A
with peak activity estimated at pH 8.07, 7.6 and 7.75 respectively.
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A bell-shaped pH profile with peak activity at pH 8 was observed for each enzyme. Wildtype BjPutA, BjPutA 1-986 and C792A reached maximal PRODH activities of 5.74, 6.56
and 7.27 µM o-AB-P5C/min, respectively. The pH profiles are similar to that observed
for monofunctional Put1p from S. cerevisiae (Chapter 2).
The Km and specificity constant (kcat/Km) of P5CDH activity of wild-type BjPutA,
BjPutA 1-986, and BjPutA mutant R456M were determined at different pH. For all three
BjPutA enzymes, a plot of kcat/Km versus pH yields a bell-shaped curved with kcat/Km
maximum at pH 7 (Figure 8A). At pH 9.0, kcat/Km decreases by > 10-fold to about 200 M1

sec-1 compared to 2600-3600 M-1 sec-1 at pH 7. The sharp decrease in kcat/Km at pH >

7.0 may be attributed to less favorable P5C/GSA equilibrium or a change in substrate
binding. A plot of Km versus pH (Figure 8B) shows that Km for P5C/GSA does not
significantly increase until pH > 8.5 with Km values for P5C/GSA estimated above 10
mM at pH 9.0 for wild-type BjPutA and R456M and, above 30 mM at pH 9.5 for BjPutA
1-986.
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Figure 8- pH profile of P5CDH kinetic parameters. A) Specificity constant (kcat/Km)
for BjPutA, BjPutA 1-986 and R456M P5CDH domains plotted versus pH. The pH
profiles were fit to equation 4.1 in SigmaPlot 12 (Systat Inc.). The solid line, dotted line
and dashed line correspond to the fit for BjPutA, BjPutA 1-986 and R456M with peak
activity estimated at pH 6.86, 6.89 and 6.75, respectively. B) Plot of Km (P5C/GSA mM)
for P5CDH activity versus pH. Significant increase in Km was observed at pH > 8.5.
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DISCUSSION
Truncation of C-terminal residues (987-999) in PutA from B. japonicum was
expected to increase solvent accessibility to the substrate channel by creating an
additional opening into the cavity between the PRODH and P5CDH active sites. Thus, it
was hypothesized that the truncated BjPutA 1-986 mutant may partially leak the
intermediate P5C/GSA into the bulk solvent. In previous studies on BjPutA [4], the
appearance of the intermediate P5C in the bulk medium was studied using a trapping
assay using o-AB. In the trapping assays inverted membrane vesicles from E. coli (putAstrain) [15] were used as terminal electron acceptor in the absence and presence of 0.2
mM NAD+. From the results of these assays, 70% of the P5C/GSA was estimated to
directly channel from PRODH to P5CDH in wild-type BjPutA [4]. Unlike wild-type
BjPutA, BjPutA 1-986 does not exhibit turnover with inverted membrane vesicles (data
not shown). The lack of functional PRODH activity with membrane vesicles suggests
that residues 987-999 are also important for BjPutA membrane binding. Thus, residues
987-99 appear not only to be important for forming the channel but also have a role in
functional membrane binding. Because BjPutA 1-986 does not bind to membranes, it is
not possible to directly compare the channeling efficiency of BjPutA 1-986 with wildtype PutA. Transient time analysis shows that truncation of the C-terminal residues of
BjPutA increases the time required to achieve steady-state formation of NADH. Steadystate formation of NADH is reached at approximately 2.5 min for BjPutA 1-986, which is
significantly longer than the ~ 10 sec lag time observed with wild-type BjPutA. These
results indicate that P5C/GSA leaks into the bulk solvent in assays with BjPutA 1-986
consistent with increased solvent access to the substrate channeling cavity as predicted by
the BjPutA structure.
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The equilibrium of the intermediates P5C and GSA is pH dependent with the
open-chain GSA favored at pH < 6.6 [6]. It is not known where the obligate hydrolysis
step occurs in BjPutA. Structural analysis of the P5CDH active site indicates that P5C
and GSA can both bind to the active site. The observation that proline inhibits TtP5CDH
(Chapter 2) suggests that P5C may bind at the P5CDH active site and that the hydrolysis
step occurs in the active site. We hypothesized that the substrate channel may facilitate
the P5C/GSA equilibrium by increasing the pKa of the pyrrolinium species above pH 6.6,
making the hydrolysis of P5C to GSA more favorable at physiological pH conditions.
Because BjPutA 1-986 was considered to have a more solvent exposed substrate channel,
it was thought that the pH activity dependence of BjPutA and BjPutA 1-986 may be
different.
The pH profile of the substrate channeling reaction and the transient time,
however, showed no significant differences between wild-type BjPutA, BjPutA 1-986,
and the equimolar mixture of the BjPutA monofunctional variants. The peak activity for
substrate channeling reaction was observed at pH 6.5-7.0 for the three different enzyme
systems. The transient time to attain steady-state NADH formation remained unchanged
between pH 6-8, a range in which the equilibrium of P5C/GSA is expected to be
significantly altered by the pH environment. BjPutA 1-986 and the non-channeling mixed
variants did exhibit lag times (2.5 min and 5.3 min, respectively), but the lag times did
not appear to change until pH > 8.0. Interestingly, the transient time for wild-type
BjPutA, BjPutA 1-986, and the mixed variants all showed the same pH dependence
significant increased observed at pH > 8.0. If the substrate channel was critical for
facilitating the hydrolysis of P5C at a more physiological pH environment, then BjPutA
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1-986 and the mixed variants would have shown significantly different pH activity
dependences. The substrate channel cavity is expected to be more solvent exposed in
BjPutA 1-986 and with the mixed variants P5C/GSA must equilibrate with the bulk
solvent to form NADH. The similar pH profiles of wild-type BjPutA, BjPutA 1-986, and
the mixed variants argue against the channel facilitating the P5C/GSA equilibrium and
suggests that the hydrolysis of P5C occurs in the P5CDH active site.
To investigate the pH effect on substrate channeling further, the pH activity
dependence of the individual PRODH and P5CDH domains were assessed separately.
The pH profile of PRODH activity for wild-type BjPutA, BjPutA 1-986, and BjPutA
mutant C792A all show a bell-shaped curve with peak activity at pH 8.0. At this point it
is not clear what step in the PRODH reaction is most influencing the pH profile that is
observed for PRODH activity. A straightforward experiment that could be performed
would be to measure the rate of flavin reduction under single-turnover conditions at
varying pH. This would help dissect out the effect of pH on the substrate binding and
chemical steps of the PRODH reaction. This experiment, however, was not pursued
because of difficulties with BjPutA (20-40 µM concentration) precipitating at pH > 8.0.
The activity of P5CDH for wild-type BjPutA, BjPutA 1-986, and BjPutA R456M
was also significantly affected by pH (Figure 8 A) with peak activity at pH 7 for all three
enzymes. pH can influence factors which are important for P5CDH catalysis such as
hydrolysis of P5C to GSA, deprotonation of the active site cysteine and hydride transfer
from GSA to NAD+ [16]. Because the pH dependence of NADH formation seems to
correlate more closely with the pH activity profile of P5CDH activity, it appears that
catalytic steps in the P5CDH active site have a greater influence on the pH dependence of
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substrate channeling than the PRODH reaction. Future experiments will need to dissect
the different catalytic steps of the P5CDH reaction to provide more insights into the pH
sensitive steps of P5CDH activity and the overall BjPutA substrate channeling reaction.
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